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ABSTRACT 
Part One. X-ray crystallography has benefited from the synthetic introduction of selenium to 
different positions within nucleic acids by easing the solving of the phase problem. Interestingly, 
its addition to the 2' position of the ribose ring also significantly enhances crystal formation. 
 This phenomenon was investigated to describe the effect of selenium-based and other 2' 
modifications to the ribose ring of nucleosides in solution, as well as the incorporation of the 
selenium-modified nucleotides into a helical structure. This work correlates the difference in 
conformation propensity between the selenium containing nucleosides and oligomers towards a 
rationale behind the enhanced crystal forming behavior. Part Two. Recombinant protein 
production is a critical tool in laboratories and industries, and inducing extracellular transport of 
these products to the culture medium shows potential for improving cases where the yields are 
not sufficient in quality or quantity. This review incorporates current practices and systems with 
future perspectives.  
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PART ONE 
 
 
CONFORMATIONAL BIAS IN 2'-SELENIUM-MODIFIED NUCLEOSIDES AND THE 
EFFECT ON HELICAL STRUCTURE  
 
  
1 
1 INTRODUCTION  
1.1 Introduction to Nucleic Acid Structure 
Nucleic acids are a vital component of any biological system and as such they are 
very widely studied. The cellular processes that nucleic acids and their constituents are 
a part of span from information or energy storage to catalysis or intercellular signaling. 
The driving force behind many nucleic acid functions, from drug or protein binding4-6 to 
regulation of transcription or replication7, is its structure. A monomer nucleotide is 
characterized by a nucleosidic base, a ribose sugar and a phosphate linker moiety, all 
of which can have an effect on the macroscopic structure of the molecule, but as the 
ribose units connect the base to the phosphate backbone, and being a five-membered 
ring prone to dynamic switching, or puckering, between conformations, the character of 
the sugar has a heavy influence on the overall configuration, especially in a double-
stranded helix.  
1.2 The Concept of Pseudorotation 
The characterization of this non-planarity of a ring system using the concept of 
pseudorotation was done on cyclopentane first by Kilpatrick et al.8 and followed by 
others9 who deduced the dynamic nature of these rings through various thermodynamic 
data. The concept was expanded by Altona and Sundaralingam who combined this 
concept with X-ray crystallography data to relate the five intracyclic torsion angles of a 
nucleosidic sugar in two pseudorotation parameters: phase angle (P) and puckering 
amplitude (Φm). They showed the rings essentially exist as two main types, North (3'-
endo) and South (2'-endo), as designated by their phase angle1 (Fig. 1.1). They further 
incorporated Karplus'  relationship  between  torsion  angle  and  H-H  3J coupling 
2 
values10-11 to describe the two state equilibrium that furanose rings exhibit and through 
various refinements have allowed for quantification of the percentage of either form that 
exists at equilibrium.12 No experimental data has suggested the use of a third 
pseudorotation parameter, and it has since also been shown that different forms of 
nucleic polymers prefer different sugar conformations.13 A brief overview of trends in 
different nucleic acid structures is given in Figure 1.1. The Altona-Sundaralingam (AS) 
formalism is a powerful tool for extracting structural information based on coupling 
constants, which will be employed later.  
1.3  Nucleic Acids in X-ray Crystallography 
Since many techniques are used to investigate structural properties of nucleic 
acids, being able to reconcile the disadvantages of these techniques is beneficial to 
Figure 1.1 Pseudorotation Wheel and Sugar Puckering Conventions (Left)Pseudorotation 
wheel depicting the conformation designated by a given phase angle, P. The regions shaded 
designate the range northern (red) and southern (blue) sugars populate in the wheel. Image 
adapted from Altona and Sundaralingam (1972). (Right) Trends in nucleic acid structures, 
decreasing: helical handedness, glycosidic base orientation, sugar pucker designation, 
pseudorotation phase angle designation.1-3 (Bottom Right) Visualization of the two generalizd 
conformers discussed. 
3 
develop a clear understanding of molecular processes. X-ray crystallography has been 
used to much success to study structural characteristics of many biological 
macromolecules, but to overcome the difficulties of crystallization and phase 
determination force crystallographers to alter the natural structure of these 
macromolecules with heavy-atom soakings or modifications. An additional problem in 
this case is that methods that are very effective with proteins have been proven to be 
much more difficult in DNA and RNA.14 For instance, bromine derivatization can be 
problematic because it acts as a good leaving group and can attract nucleophilic attack 
if it is positioned anywhere on the furanose ring. Bromine addition to the base can lead 
to decomposition when exposed to UV light, as exhibited in photo-crosslinking of nucleic 
acids to proteins in order to determine contact points.15   
1.4 Selenium Modifications in Biopolymers 
Interestingly, the incorporation of selenium atoms into a macromolecule, which has 
been shown to work well in protein crystal samples,16 has recently been explored by 
Huang et al. as a method for DNA or RNA structural investigation.17-19 They have 
reported minimal disruption of structure between crystal structures of unmodified DNA 
oligomers and derivatives with 2'-selenomethyl and 5-bromine modifications, and the 
sugar pucker of all of these molecules are found to be A-form DNA, having a 3'-endo 
conformation.14 More remarkably, they also report a much quicker rate of crystal 
formation with the selenomethyl modification than the bromine derivative or the 
unmodified control,20 which raises questions about the effect the methyl-selenium 
modification has on crystal stability or desolvation rates considering the sugar pucker is 
the same in a crystal whether the 2' position is modified or not. It is also worth noting 
4 
that in solution-based biophysical studies of nucleic acids, a 2' substituent is a 
determinant of the sugar conformation and its dynamics,21-22 so its effect on crystal 
formation could be a result of this. 
1.5 Goals of This Study  
This work looks at the 2'-methylseleno derivative of uridine free in solution to 
determine its propensity towards one conformation or the other and to compare this 
behavior to that of other 2'-uridine substitutions.  It also addresses the structural origin 
for the facilitated crystal formation by investigating the duplex structures containing 
selenium modifications using NMR, melting temperatures, ethidium bromide 
fluorescence and molecular modeling. The nucleoside behavior is then compared to the 
crystal structures and other data of the selenium modified oligomers. The library of 2' 
substituted uridines is described in Figure 1.2, while the sequences used in the oligomer 
studies are presented in Table 1.1.  
Figure 1.2 Modified Nucleosides used in this study. X= H (deoxyuridine, compound 1); OH 
(uridine, 2); OCH3 (3); F (4); SCH3 (5); SeCH3 (6). 
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Table 1.1 Duplex sequences for NMR and TM studies, U
Se is compound 6 
I 5‟-d(CATGCATG) 
II 5‟-d(GCGAATTCGC) 
III 5‟-d(GCGAAUSeTCGC) 
IV 5‟-d(CGCGAATTCGCG) 
2 MATERIALS AND METHODS 
2.1  Nucleoside Studies 
The sulfur and selenium based modifications were prepared as reported,14,23 and all 
other compounds were purchased from Tech Chem. Nucleoside experiments were 
performed with a Bruker Avance 500 MHz spectrometer equipped with a TBI triple-
resonance broadband capable probe head at 298K. Samples were prepared to be 1.0 
mM nucleoside in D2O with 10 mM sodium phosphate adjusted to pH* 6.0. DSS was 
used as an internal standard. Routine 1D 1H NMR experiments with water presaturation 
pulses were performed on each nucleoside in order to confirm purity of the samples and 
to measure coupling constants. Double quantum filter COSY experiments (32 scans) 
were recorded to confirm assignments.  A low-flip angle COSY was recorded for 
deoxyuridine (1) to clarify couplings caused by the 2' and 2" protons. 
2.2 Computational Parameters 
DAISYSIM, a component of Topspin 2.1 (Bruker), was used to simulate spectra 
from the acquired NMR data in order to precisely determine the individual couplings and 
chemical shifts.  DAISYSIM refines coupling and chemical shift estimates by a user-
directed iteration algorithm. The refined coupling constants were used as the input into 
PSEUROT 6.024 to calculate the pseudorotation parameters according to established 
6 
practices. Also, in an attempt to move from a command line style of input to a more 
modern, user-friendly, GUI-based computational method, a Matlab-based (Mathworks) 
pseudorotation program was used for further substantiation.25 PSEUROT 6.0 has been 
used to much success to calculate pseudorotation parameters of pentose rings from 
NMR data in several instances26-28 and was provided by Altona and de Leeuw. The 
Matlab program was provided through a GNU General Public License by Hendrickx and 
Martins. The computation for each compound was initially set up with the conditions 
described in the user's manual of PSEUROT 6.0. The initial %S conformer was varied in 
subsequent trials in order to alleviate any bias built into the program with respect to 
conformational preference. Each of these initial states was refined during the 
computation by each program to give a theoretical pure N- and S-conformer population 
which was used to fit the data.  The change in electronegativity of the 2' substitutions 
was accounted for in the input file; the values are derived from a Huggin's based 
electronegativity scale referenced to hydrogen specifically for use with generalized 
Haasnoot-Karplus equation as suggested by the authors of PSEUROT 6.0.29-32 The 
Matlab program, since it was designed with the same computational premises, 
suggested the same values in the User's Manual.25 The input and output data from each 
program are compiled in the Appendices.  
2.3  Melting Temperature Assays 
The melting assay was performed on the control and modified duplexes (II and III, 
respectively), through absorbance monitoring at 274 nm. The buffer was prepared to 
400 mM sodium chloride, 10 mM sodium phosphate, and 0.1 mM EDTA at pH 6.5. The 
concentration of the both strands was set to 8 μM. Also, a second selenium sample was 
7 
prepared in the same buffer with 32 μM DNA in order to quantify the effect of 
concentration on the formation of a duplex. During the TM assay, the temperature was 
reversibly ramped from 20oC to 90oC at 0.3oC/ min, controlled by a Cary spectrometer 
and heating block. 
2.4 Ethidium Bromide Fluorescence 
Oligomer samples of increasing length (octamer: I, decamer: II, Se-decamer: III, 
dodecamer: IV) were 15 µM in nucleotides or ~0.8 µM in duplex concentration and 
contained 1 µg/mL ethidium bromide, 100 mM NaCl, 10 mM sodium phosphate and 0.1 
mM EDTA at pH 6.5. Samples were individually placed into PCR tubes and imaged on a 
Typhoon 9400 Variable Mode Imager from Amersham Biosciences. Excitation for 
imaging occurred at 532 nm and emission was measured at 610 nm. 
2.5 Imino Proton Observation 
NMR samples of sequences II and III were prepared at 50mM sodium chloride, 10 
mM sodium phosphate, 0.1 mM EDTA and pH 6.4 in 9:1 H2O:D2O. Imino proton spectra 
were recorded on an Avance 600 MHz spectrometer using jump and return water 
suppression according to established practice.33 Selenium samples (sequence III) were 
prepared at strand concentrations of 100 and 20 µM (designated high and low, 
respectively). The control sequence was prepared at 250 µM, in order to minimize 
acquisition time. 
2.6 Model Development 
Standard A- and B-form DNA helical models of sequence III were built within 
Spartan06 (Wavefunction) to estimate the position of 2‟-SeCH3-modification inside each 
8 
secondary structure. The A-form set the sugar puckering as N–type and with a rise and 
twist of 2.548 Å and 32.7o per base, respectively, as described in the Spartan manual. 
The second model was made to be B-form (S-type, 3.375 Å, 36o). After the models 
were built, the modification was inserted into the 2‟ position. 
3 RESULTS 
3.1 Data Fitting and NMR Assignments 
In order to obtain an accurate description of the relevant coupling constants from 
the NMR data, the spectra were simulated from within TOPSPIN 2.1. In order for the 
simulation to be properly designed, the proper assignment of residues is critical. 2-D 
COSY spectra for each compound in Figure 1.2 were obtained to fully assign the peaks 
with high confidence. The correlation of resonances seen in the spectra was used to 
fully assign the sugar ring protons.  The diagonal peaks arise from the peaks in each 
dimension seeing themselves (i.e. y = x), and from the diagonal one can determine 
which other peaks are within 3 bonds of the peak of interest. Knowing that the 1‟ proton 
should only see one resonance, one can follow the rest of the correlation pathway 
around the ring. Figure 3.1 shows the COSY spectrum of compound 6, with the pathway 
highlighted. This strategy was repeated for each compound in this study and the full 
assignment of the ring protons was determined. Using the assignments, the inputs for 
the simulations were created. 
Using DAISYSIM, a spin system simulation was fit to the NMR data according to 
a qualitative assessment by the user, i.e. if the simulation has not been accurately laid 
over the actual data, then further simulations and refinements are made in a recursive 
9 
fashion until the simulation fits the data appropriately. This trial and error type method 
worked well in this situation but might not be the most effective way to determine 
obscure coupling constants from complicated systems. Nevertheless, this method was 
able to simulate the data to a high level of accuracy, although there was not an RMSD 
value returned by the fitting program, the experimental data and the simulation 
corresponded to each other fluently. Figure 3.2 shows the data fitting in the 
Figure 3.1 COSY spectrum of 2'-methylseleno-uridine, compound 6. Assignment pathways 
are colored.  
10 
1-D 1H spectra of compounds 1 and 6. Upon first looking at the spectra, without 
considering the COSY spectra, the splitting patterns make sense when comparing the 
two. The 1‟ proton is split by two signals in the spectrum of compound 1, corresponding 
to the 2‟ and 2” protons. In compound 6‟s spectrum, the 1‟ peak is only split by one 
proton, at the 2‟ position, because the 2” proton has been replaced by the methylseleno 
group in compound 6. The 3‟ signal in 1‟s spectrum is split by an extra signal as well, as 
evident when comparing to 6, following the same logic. This observation combined with 
the COSY spectra gives a high level of confidence in the data obtained from the 
simulations.  
Figure 3.2 Simulation vs. NMR Data. (A) Deoxyuridine, compound 1. (B) 2‟-selenomethyl-
deoxyuridine, compound 6. Blue line is NMR data, red line is simulation results. 
11 
3.2 Nucleoside Characterization via Pseudorotation Calculations 
The data from the NMR experiments is the backbone of the subsequent study, 
and all of the coupling values obtained by fitting the raw data in DAISYSIM were used in 
the pseudorotational calculations. The experimental data is compiled in Table 3.1 and 
shows reasonable correlation with literature reports. The trends in 3J values and 
chemical shift with respect to substituent identity begin to reveal themselves even 
before pseudorotation parameters are calculated, and hint at the behavior of the sugar 
ring and the effects of the different modifications. Specifically, the 3J1‟-2‟ and 
3J3‟-4‟ values, 
which arguably are the most affected by a change from 2‟-endo to 3‟-endo 
conformations, are the most dynamic of the data collected and sets the stage for 
explanation through a pseudorotation perspective. The fitted coupling data was used as 
the input parameters for the calculation of pseudorotation values as described in 
Section 2.2. Since all endocyclic coupling constants were known, the discrepancies 
arising from the mathematical determination of pseudorotation parameters, i.e. five 
torsion angle expressions with five variables, were minimized by eliminating solutions 
which did not fit within the whole set of equations. The optimized conformations and the 
percent of each were similar between PSEUROT and Matla and correlated with 
published results.23,34-37 In Table 3.1, the top portion tabulates the NMR data, while the 
bottom portion shows the output from PSEUROT 6.0 (PS) and the Matlab program 
(ML). The pseudorotation data is also compiled in Table 3.1. It is interesting to see how 
the two starting conformations do not differ much between compounds, (the range is 
roughly 50o) but the percent S conformation varies significantly. The data is believable 
because it follows literature reporting and implies that an increase in substituent electro-
 
 
 
1
2 
 
Table 3.1 Compiled NMR and Pseudorotation Data 
 
X H OH OCH3 F* SCH3 SeCH3 
  Exp Lit
35
 Exp Lit
35
 Exp Lit
34
 Exp Lit
35
 Exp Lit
23
  Exp 
J1'-2' 7.2 6.3 4.5 4.2 3.9 3.6 1.4 1.5 8.3 8.5 8.7 
J 1'-2'' 6.1 6.4         19.7 19.7       
J 2'-3' 6.9 6.3 5.3 5.3 5.2   5.0 5.1 5.8 5.5 5.7 
J2''-3' 3.9 4.3         21.5 21.6       
J 3'-4' 3.9 4.0 5.5 5.7 5.7   8.6 8.7 2.8 2.0 2.9 
J H5-H6 8.1 8.1 8.1 8.0 8.1 8.3 8.1 8.1 8.1   8.1 
δ2' 2.4 2.4 4.3 4.3 4.1   5.2 5.2 3.6 3.4 3.6 
δ4' 4.0 4.0 4.1 4.1 4.1   4.2 4.1 4.2 3.9 4.1 
  PS ML Lit
35
 PS ML Lit 
35
 PS ML Lit 
34
 PS ML Lit 
35,36
 PS ML Lit 
23,37
 PS ML 
I.                                   
N Type                                   
P 18.0 2.3 18 32.4 13.5 18 12.5 34.4 11 28.6 36.1 21 -22.5 50.6 -- -13.3 7.2 
ΦM 38.0 33.5 -- 32.0 30.5 -- 32.0 35.5 35 32.0 34.2 -- 32.0 16.7 -- 32 20.3 
                                    
II.                                   
S type                                   
P 141.5 149.7 162 156.6 129.40 162 144.7 162.7 171 38.6 -4.0 159 138.7 127.1 -- 137.6 134.7 
ΦM 32.3 22.9 -- 35.0 41.70 -- 35.0 30.9 37 35.0 34.2 -- 35.0 45.1 -- 35.0 40.4 
                                    
%S 0.67 0.58 0.6 0.40 0.45 0.4 0.38 0.39 0.4 0.32 0.03 0.17 0.81 0.76 0.76 0.84 0.83 
 
 
13 
negativity will drive the system into a state with a higher %N conformation,38 as 1 favors 
a predominately S mixture while 2, 3, and 4 prefer an increasingly N mixture. 
Compound 4, despite varying the starting conditions with different starting mixtures, 
converged to „equilibrium‟ where both conformers were of N-type, essentially implying 
that the S-type conformer does not exist free in solution under these conditions. Both 
PSEUROT and Matlab returned this output. The literature shows that chlorine and 
bromine substitutions fit the overall relationship between electronegativity and percent 
S; the report of a 50-50 mixture of conformers makes sense36 as these atoms have an 
electronegativity value less than oxygen but more than hydrogen. This trend is no 
longer observed, however, when considering the sulfur and selenium based 
compounds. Compounds 5 and 6 are found to more strongly prefer the S conformation 
than compound 1 in solution, which is the opposite of what the electronegativity or 
crystal structures suggest. Since the programs correlate well with literature results, a 
computational error is unlikely and an inference can be made that steric effects between 
the 2' substituents and the base drive the preference of the S conformation.  There is 
strong correlation between various NMR data points and the %S value, which is an 
intrinsic principle of the programs themselves, but suggests that reasonable prediction 
of sugar puckering dynamics can be made from raw NMR data. As stated above, the 
3J1‟-2‟ and 
3J3‟-4‟ values are the most dynamic because they are the most affected by a 
change from 2‟-endo to 3‟-endo conformations. Especially relevant is the 3J3‟-4‟ couplings 
because they are affected by the ring dynamics, and would be only minimally impacted 
by the 2'-substituent identity and when plotted against %S, as in Figure 3.3, show linear 
behavior. This expands on the graphical method presented by Rinkel and Altona,39  
14 
and works when individual couplings are known. These results clearly establish that 2'-
SeCH3-modified nucleosides strongly prefer a 2'-endo conformation in solution. 
However, this is exactly the opposite of what is observed in the crystal structures. This 
discrepancy was an interesting revelation and prompted further investigation of 
selenium-containing nucleosides within a duplex in solution.  
3.3 Duplex Stability 
In order to gain perspective on the physical effects of the 2‟-SeCH3-modification 
to a double stranded DNA molecule in solution, fluorescence, TM and NMR data were 
Figure 3.3 Relationship between 3J3‟-4‟ coupling constant (Hz) and %S conformation 
15 
acquired and examined. The results of the ethidium bromide intercalation study (Figure 
3.4) showed a clear discrepancy in the fluorescence of the different samples. The  
fluorescence intensity typically increases as a function of oligonucleotide length as more 
intercalation sites are possible in longer sequences. The unmodified octamer, decamer, 
and dodecamer exhibited this behavior. However, the Se-decamer displayed a lower 
fluorescence than the octamer, alluding to the destabilization effects of the modification.  
The difference in melting curves between the unmodified decamer and the 
selenium decamer is also immediately noticed. The stability of the self complementary 
sequence III containing one 2‟-SeCH3-modification and its control II was determined by 
UV melting (Figure 3.5). The control duplex forms a standard B-type helical structure 
and exhibits a regular melting profile with an expected stability.40-41 On the other hand, 
the shifted and shallow melting curve for the DNA strand III containing a single 2‟-
SeCH3-modification demonstrates through a change in hyperchromicity that duplex 
formation was seriously destabilized.  The observation that the denaturation was not 
concentration dependent also suggests the involvement of intramolecularly formed 
Figure 3.4 Duplex stability from ethidium bromide fluorescence. DNA samples (Octamer: I, 
Decamer: II, SeDecamer: III, Dodecamer VI) containing contain 1µg/mL ethidium bromide were 
placed in PCR tubes and imaged (Excitation at 532 nm, emmision at 610 nm). Relative 
fluorescence data, corrected for the blank, is indicated for each sample. 
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hairpin structures. This data makes sense when compared to the imino proton spectra. 
The unmodified decamer II is shown to have five imino proton resonances, consistent 
with the C2 rotational symmetry of a duplex structure (Figure 3.6A). In contrast 
sequence III, at 100 µM strand concentration, showed more imino proton resonances 
than would be expected for a duplex (Figure 3.6B). This strongly indicates the presence 
of multiple structures. Of note, there are resonances near 10.8 ppm that are generally 
associated with unpaired hairpin loop resonances.42-43 If duplex III is examined at 20 μM 
strand concentration the spectrum simplifies and essentially only 3 GC base pairs are 
observed in addition to the hairpin loop resonances (Figure 3.6C). Under these 
Figure 3.5  Duplex stability from UV Melting curves.  Samples were prepared in 400 mM 
NaCl, 10 mM NaPi, 0.1 mM EDTA at pH 6.5. The unmodified control decamer (II, ♦) at 8.5 µM 
showed a TM of 59
oC and two different concentrations of the selenium decamer (III) were 
compared, 8.5 µM (■) and 32 µM (●), both of which had an estimated TM of 41
oC. 
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conditions the predominant species is a hairpin structure with a stem consisting of 3 GC 
base pairs. Salon et al. have previously demonstrated complete base pairing for a non- 
self-complementary duplex containing a single 2‟-Se-modification.44 However the 
stability was compromised in this construct as well and homoduplex formation of the 
individual strands was observed at elevated temperatures. Taken in context, all of this 
data demonstrates that a 2‟-selenomethyl group destabilizes a B-type DNA helix in 
Figure 3.6  Imino proton spectra of sequences II and III at 288 K (A) The control decamer (II, 
250 µM strand concentration) spectrum shows the presence of five base pairs. (B) and (C) are 
the selenium-containing decamer (III) at high and low strand concentration (100 and 20 µM, 
respectively). Arrows highlight resonances that disappear upon dilution. These signals are also 
sensitive to increased temperatures. Peaks are referenced to DSS. 
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solution, even though this modification has an intrinsic preference for a southern sugar 
conformation, as demonstrated by the nucleoside study.  
3.4  Crystal Structures and Models 
Zhen Huang's group has made several selenium modified nucleosides and 
solved crystal structures with these analogs incorporated into a DNA helix (pdb: 1MA8, 
3IFF, 2NSK, 2HC7, 2DLJ).14,20 In every case, whether the 2'-selenomethyl-modification 
is present or not, the helix exhibits A-type, predominately N-sugar behavior. Even in 
1MA8, where the selenomethyl groups are opposite and adjacent to each other, which 
was shown above to not exist in solution at room temperature, they situate themselves 
into the minor groove in a complete duplex (Figure 3.7a). Considering how deoxyuridine 
and 2'-methylseleno-uridine both prefer the S-conformation in solution, there has to be a 
driving force behind this change in overall sugar conformation. To obtain further insight 
why 2‟-methylseleno-uridine (6) adopts a northern conformation when part of a DNA 
duplex, as seen in crystal structures, standard A- and B- type DNA helical models45 with 
the appropriate modifications (i.e. sequence III) were investigated.  The A-type helix 
containing the Se-modification was homologous to the crystal structures published in 
the literature. There are no steric clashes with the backbone, neighboring bases or 
deoxyribose ring.  In contrast, in the B-helical model the modification is situated in the 
major groove, but the 3‟ phosphate as well as the base on the 3‟ side of the modification 
clash with selenomethyl group.  This is especially apparent when the 3‟ base is thymine 
whose methyl group is also in the major groove.  Therefore, a base with a smaller 
footprint in the major groove would be expected to be less perturbed which agrees with 
our previous NMR data where the 2‟ modified residue was flanked by cytosines.44 To 
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Figure 3.7 2’ Se-CH3 groups incorporated in A and B helical structures. Panels A and B 
represent Connelly surfaces with the Se-CH3 group depicted as VdW representation in orange. 
In panel C and D the bases and sugars are shown in green and Se-CH3 is depicted as VdW 
spheres. A) The group is nestled comfortably in the minor groove of an A-type helix (pdb: 
1MA8). C) No clashes are apparent between the 3‟ neighboring residue and Se-CH3 . The blue 
dotted spheres depict VdW spheres of close atoms. B) In a B-type helical model 
(dGCGAAUSeTCGC) the Se-CH3 group points away from the major groove but experiences 
significant clashes with the backbone as well as the base on the 3‟ side of the modification, 
which would disrupt base stacking. D) Predicted clashes for the B helix model are indicated with 
red VdW spheres for backbone (O and P) as well as the base (CH3 and H6). 
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reiterate, the B-type model is intended to be a qualitative picture of how the selenium 
modification affects the stability of a B-type helix. There were no molecular dynamics 
simulations because there is no experimental data from which restraints could be 
obtained.   
4 CONCLUSIONS 
The notion that the southern sugar conformation is not tolerated well in a B-helix 
because of steric interactions explains the solution-based structural data but could also 
rationalize the enhanced crystal growth. DNA∙RNA hybrids have been shown to form A-
type structures, and alkylation of the 2‟-hydroxyl group has been shown to increase the 
stability of these structures by lowering the intrinsic nucleophilicity of the hydroxyl group 
and altering the hydrogen bonding pattern. Addition of a methyl group no longer allows 
the hydroxyl group to act as a donor in a hydrogen bonding pair, and can now only 
accept hydrogen bonds. This effect has been said to drive local structure towards an A-
type helix.21 Divalent selenium atoms, as in compound 6, can form hydrogen bonds with 
donor atoms, but because selenium has limited ability for induced dipoles due to its 
size, these bonds are very weak46 and most likely has an influence on the hydrogen 
bonding network around the modification. Also, it has been proposed that the hydration 
of the minor groove will be affected by the pattern of purines and pyrimidines when a 2‟-
modification is made,21 but recent data showed that the nature of the base of the 
modified nucleotide is not a determining factor as enhanced crystal growth was also 
observed for other 2‟-selenomethyl-modified nucleotides.47-49  Thus, the following can be 
concluded:  
21 
A single 2‟-selenomethyl group narrows the conformational space by destabilizing 
the B-helical form while promoting A-helix formation.   Moreover, the 2‟-methylseleno 
group fits snuggly into the minor groove of an A-helix and can serve as the origin for a 
B- to A- conversion, which is also aided by dehydration during crystallization. In 
addition, the 2‟-selenomethyl group locally dehydrates the minor groove which further 
facilitates the crystallization process. The impact of this behavior suggests that this 
modification could be used in samples that have been difficult to crystallize for their 
structural determination, yet consideration must be given to the fact that the 
conformational bias imparted by the modification could disrupt the normal behavior of 
the sample in solution. Positioning the modification in a place within a hairpin loop or on 
the 5‟ side of a less-bulky purine base are the least likely to distort the structure by steric 
interactions. 
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6 Appendix 
6.1 Appendix A - Reconstructed PSEUROT Batch File 
 
::This batch file was reconstructed from the version contained in a degraded copy of PSEUROT 
::that had been copied multiple times over a few years. As I am not a computer programmer, 
::I'm not entirely sure why it works, but it does. When using the command line context 
::described in the manual, this .bat file correctly renames inputs and outputs for use in the 
::PSEUROT program, and the output files are competent. PSEUROT is able to run to completion, 
::which is stated at the end of the output files. However, the‘MANY’functionality does not 
::work to completion. 
@ECHO OFF 
if '%1'=='' goto Usage 
copy %1 %1.inp 
copy %1.inp pseurot6.inp 
psrot62 <pseurot6.inp >pseurot6.out 
if exist pseurot6.out    copy pseurot6.out %1.out >NUL 
if exist pseurot6.mn1    copy pseurot6.mn1 %1.mn1 >NUL 
if exist pseurot6.mn2    copy pseurot6.mn2 %1.mn2 >NUL 
if exist pseurot6.mn3    copy pseurot6.mn3 %1.mn3 >NUL 
if exist pseurot6.mn4    copy pseurot6.mn4 %1.mn4 >NUL 
if exist pseurot6.mn5    copy pseurot6.mn5 %1.mn5 >NUL 
:pkzip %1.zip %1.inp %1.mn1 %1.mn2 %1.mn3 %1.mn4 %1.mn5 :goto Einde 
:Usage 
 echo Usage: PS62 filename 
 echo where filename does not have an extension 
 echo. 
:Einde  
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6.2 Appendix B – Inputs and Results for PSEUROT 6.0 Calculations 
6.2.1 2'-Deoxyuridine 
Trial 1 Input 
dU 
CTRL  MAXIT 25  TRIM 0.1  RCNV 0.5  PRINT 1 
DATA 5 
1'-2'    -144.0       1.030   121.4       0.72      1.27      0.00      0.62 
1'-2"    -144.0       1.020     0.9       0.72      1.27      0.62      0.00 
2'-3'       0.0       1.060     2.4       0.62      0.00      1.26      0.62 
2"-3'       0.0       1.060   122.9       0.00      0.62      1.26      0.62 
3'-4'     144.0       1.090  -124.0       0.72      1.26      1.27      0.68 
TSET 1 
298       7.19  6.14  3.89  6.9  3.89 
START  26.0      38.0     164.0      38.0   .78 
FITF 00111 
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Trial 1 Output 
 
+++++++++++++++++++++++++++++++++++++++++++++++++++++++     
+  PSEUROT v 6.0                          March 1993  +     
+  John van Wijk                       FAAM de Leeuw  +     
+  Gorlaeus Laboratories, State University of Leiden  +     
+++++++++++++++++++++++++++++++++++++++++++++++++++++++     
 
++++ CASE :  1 +++++++++++++++++++++++++++++++++++++++++++++ PSEUROT 6.0 +++++ 
 
TITLE: 
dU 
The minimization has converged. 
============================================================================== 
 F I N A L   O U T P U T                                                      
============================================================================== 
Total number of iterations:  9 
 
CONFORMER I:                             CONFORMER II: 
 
      P ==    18.0  (  .314 RAD)             P ==   184.6  ( 3.222 RAD) 
   PHIM ==    38.0  (  .663 RAD)          PHIM ==    59.7  ( 1.041 RAD) 
 
  PHIHH =    98.4    ==> JHH =   1.22    PHIHH =   168.0    ==> JHH =  11.24 
  PHIHH =   -21.9    ==> JHH =   7.70    PHIHH =    47.1    ==> JHH =   4.11 
  PHIHH =    40.7    ==> JHH =   6.56    PHIHH =   -60.6    ==> JHH =   2.04 
  PHIHH =   161.2    ==> JHH =  10.01    PHIHH =    59.9    ==> JHH =   3.50 
  PHIHH =  -163.4    ==> JHH =   8.81    PHIHH =   -68.5    ==> JHH =   1.58 
 
TEMP SET                   298 
            JEXP   JCAL   JDIF 
   1'-2'    7.19   7.07    .12 
   1'-2"    6.14   5.60    .54 
   2'-3'    3.89   3.92   -.03 
   2"-3'    6.90   6.21    .69 
   3'-4'    3.89   4.59   -.70 
X(1)X(2)     .42    .58   .505 
 
ERROR ANALYSIS:  
ROOT MEAN SQUARE DEVIATION OF THE FIT:      .505 
STANDARD DEVIATION IN PARAMETERS: 
    0      .208      .112      .061 
 
CORRELATION MATRIX OF PARAMETERS 
 
PAR.       1          2          3 
 1      1.000 
 2       .305      1.000 
 3       .509       .212      1.000 
 
END OF THE PROGRAM PSEUROT 6.0 
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Trial 2 Input 
 
dU_databse parameters 
CTRL  MAXIT 25  TRIM 0.1  RCNV 0.5  PRINT 1 
DATA 5 
1'-2'    -144.0       1.030   121.4       0.56      1.26      0.00      0.62 
1'-2"    -144.0       1.020     0.9       0.56      1.26      0.62      0.00 
2'-3'       0.0       1.060     2.4       0.62      0.00      1.26      0.62 
2"-3'       0.0       1.060   122.9       0.00      0.62      1.26      0.62 
3'-4'     144.0       1.090  -124.0       0.67      1.26      1.26      0.68 
TSET 1 
298       7.19  6.14  3.89  6.9  3.89 
START  18.0      38.0     162.0      33.0   .78 
FITF 00111 
 
Trial 2 Output 
 
The minimization has converged. 
=============================================================================== 
 F I N A L   O U T P U T                                                      
=============================================================================== 
Total number of iterations:  8 
 
CONFORMER I:                             CONFORMER II: 
 
      P ==    18.0  (  .314 RAD)             P ==   181.0  ( 3.159 RAD) 
   PHIM ==    38.0  (  .663 RAD)          PHIM ==    59.1  ( 1.032 RAD) 
 
  PHIHH =    98.4    ==> JHH =   1.29    PHIHH =   170.0    ==> JHH =  11.63 
  PHIHH =   -21.9    ==> JHH =   8.03    PHIHH =    49.0    ==> JHH =   3.87 
  PHIHH =    40.7    ==> JHH =   6.56    PHIHH =   -60.2    ==> JHH =   2.08 
  PHIHH =   161.2    ==> JHH =  10.01    PHIHH =    60.3    ==> JHH =   3.45 
  PHIHH =  -163.4    ==> JHH =   8.86    PHIHH =   -71.2    ==> JHH =   1.43 
 
TEMP SET                   298 
            JEXP   JCAL   JDIF 
   1'-2'    7.19   7.18    .01 
   1'-2"    6.14   5.66    .48 
   2'-3'    3.89   4.01   -.12 
   2"-3'    6.90   6.27    .63 
   3'-4'    3.89   4.63   -.74 
X(1)X(2)     .43    .57   .487 
 
ERROR ANALYSIS:  
ROOT MEAN SQUARE DEVIATION OF THE FIT:      .487 
STANDARD DEVIATION IN PARAMETERS: 
    0      .224      .107      .057 
 
CORRELATION MATRIX OF PARAMETERS 
 
PAR.       1          2          3 
 1      1.000 
 2       .187      1.000 
 3       .503       .148      1.000 
 
END OF THE PROGRAM PSEUROT 6.0 
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6.2.2 Uridine 
Trial 1 Input 
 
rU_database_parameters 
ctrl  maxit 25  trim 0.1  rcnv 0.5  print 1 
data 3 
1'-2'      -144.0       1.102    123.3       0.56      1.26      1.26      0.62 
2'-3'         0.0       1.090      0.2       0.62      1.26      1.26      0.62 
3'-4'       144.0       1.095   -124.9       0.62      1.26      1.26      0.68 
tset 1 
298       4.5  5.3  5.5 
start  18.0      32.0     153.6      35.0   .20 
fitf 10101 
 
Trial 1 Output 
 
rU_database_parameters                                                           
MAXIMUM NUMBER OF ITERATIONS 25 REACHED. 
 
=============================================================================== 
 F I N A L   O U T P U T                                                      
=============================================================================== 
Total number of iterations: 25 
 
CONFORMER I:                             CONFORMER II: 
 
      P ==    32.4  (  .566 RAD)             P ==   156.6  ( 2.733 RAD) 
   PHIM ==    32.0  (  .559 RAD)          PHIM ==    35.0  (  .611 RAD) 
 
  PHIHH =   110.3    ==> JHH =   1.53    PHIHH =   160.9    ==> JHH =   8.89 
  PHIHH =    29.6    ==> JHH =   5.47    PHIHH =   -34.8    ==> JHH =   5.03 
  PHIHH =  -159.9    ==> JHH =   8.53    PHIHH =  -105.4    ==> JHH =   1.04 
 
TEMP SET                   298 
            JEXP   JCAL   JDIF 
   1'-2'    4.50   4.50    .00 
   2'-3'    5.30   5.29    .01 
   3'-4'    5.50   5.50    .00 
X(1)X(2)     .60    .40   .004 
 
ROOT MEAN SQUARE DEVIATION OF THE FIT:      .004 
 
 
FIT   3 OBS TO   3 PARS -> ERROR ANALYSIS OMITTED 
 
END OF THE PROGRAM PSEUROT 6.0 
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6.2.3 2'-Methoxy-Uridine 
Trial 1 Input 
 
OMe_database_parameters 
ctrl  maxit 25  trim 0.1  rcnv 0.5  print 1 
data 3 
1'-2'      -144.0       1.102    123.3       0.56      1.26      1.26      0.62 
2'-3'         0.0       1.090      0.2       0.62      1.26      1.26      0.62 
3'-4'       144.0       1.095   -124.9       0.62      1.26      1.26      0.68 
tset 1 
298       3.9  5.2  5.7 
start  18.0      32.0     153.6      35.0   .20 
fitf 10101 
 
Trial 1 Output 
 
OMe_database_parameters                                                          
MAXIMUM NUMBER OF ITERATIONS 25 REACHED. 
 
============================================================================= 
 F I N A L   O U T P U T                                                      
============================================================================= 
Total number of iterations: 25 
 
CONFORMER I:                             CONFORMER II: 
 
      P ==    12.5  (  .218 RAD)             P ==   144.7  ( 2.526 RAD) 
   PHIM ==    32.0  (  .559 RAD)          PHIM ==    35.0  (  .611 RAD) 
 
  PHIHH =    99.9    ==> JHH =    .80    PHIHH =   161.9    ==> JHH =   8.99 
  PHIHH =    34.3    ==> JHH =   5.08    PHIHH =   -30.9    ==> JHH =   5.37 
  PHIHH =  -157.0    ==> JHH =   8.18    PHIHH =  -112.6    ==> JHH =   1.64 
 
TEMP SET                   298 
            JEXP   JCAL   JDIF 
   1'-2'    3.90   3.90    .00 
   2'-3'    5.20   5.19    .01 
   3'-4'    5.70   5.70    .00 
X(1)X(2)     .62    .38   .007 
 
ROOT MEAN SQUARE DEVIATION OF THE FIT:      .007 
 
 
FIT   3 OBS TO   3 PARS -> ERROR ANALYSIS OMITTED 
 
END OF THE PROGRAM PSEUROT 6.0 
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6.2.4 2'-Fluoro-Deoxyuridine 
Trial 1 Input 
 
::F, trial 1, electronegativity changes based on table V B in full description 
 
2F_database_parameters 
ctrl  maxit 25  trim 0.1  rcnv 0.5  print 1 
data 3 
1'-2'      -144.0       1.102   123.3       0.56      1.26      1.37      0.62 
2'-3'         0.0       1.090    0.2       0.62      1.37      1.26      0.62 
3'-4'       144.0       1.095   -124.9       0.62      1.26      1.26      0.68 
tset 1 
298       1.38  5.0  8.6 
start  18.0      32.0     153.6      35.0   .20 
fitf 10101  
 
Trial 1 Output 
 
2F_database_parameters  
The minimization has converged. 
 
=============================================================================== 
 F I N A L   O U T P U T                                                      
=============================================================================== 
Total number of iterations:  9 
 
CONFORMER I:                             CONFORMER II: 
 
      P ==    30.5  (  .533 RAD)             P ==   150.6  ( 2.629 RAD) 
   PHIM ==    32.0  (  .559 RAD)          PHIM ==    35.0  (  .611 RAD) 
 
  PHIHH =   109.3    ==> JHH =   1.28    PHIHH =   161.6    ==> JHH =   8.71 
  PHIHH =    30.2    ==> JHH =   5.14    PHIHH =   -33.0    ==> JHH =   5.26 
  PHIHH =  -159.8    ==> JHH =   8.52    PHIHH =  -108.9    ==> JHH =   1.30 
 
TEMP SET                   298 
            JEXP   JCAL   JDIF 
   1'-2'    1.38   1.28    .10 
   2'-3'    5.00   5.14   -.14 
   3'-4'    8.60   8.52    .08 
X(1)X(2)    1.00    .00   .111 
 
ROOT MEAN SQUARE DEVIATION OF THE FIT:      .111 
 
 
FIT   3 OBS TO   3 PARS -> ERROR ANALYSIS OMITTED 
 
END OF THE PROGRAM PSEUROT 6.0 
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Trial 2 Input 
 
::"F, trial 2, predominately S" 
 
F_database_parameters_predom_S 
ctrl  maxit 25  trim 0.1  rcnv 0.5  print 1 
data 3 
1'-2'      -144.0       1.102   123.3       0.56      1.26      1.37      0.62 
2'-3'         0.0       1.090    0.2       0.62      1.37      1.26      0.62 
3'-4'       144.0       1.095   -124.9       0.62      1.26      1.26      0.68 
tset 1 
298       1.4  5.0  8.6 
start  18.0      32.0     153.6      35.0   .80 
fitf 10101 
 
Trial 2 Output 
 
F_database_parameters_predom_S 
MAXIMUM NUMBER OF ITERATIONS 25 REACHED. 
 
=============================================================================== 
 F I N A L   O U T P U T                                                      
=============================================================================== 
Total number of iterations: 25 
 
CONFORMER I:                             CONFORMER II: 
 
      P ==    28.6  (  .499 RAD)             P ==    38.6  (  .673 RAD) 
   PHIM ==    32.0  (  .559 RAD)          PHIM ==    35.0  (  .611 RAD) 
 
  PHIHH =   108.2    ==> JHH =   1.19    PHIHH =   113.0    ==> JHH =   1.63 
  PHIHH =    30.8    ==> JHH =   5.09    PHIHH =    30.0    ==> JHH =   5.16 
  PHIHH =  -159.6    ==> JHH =   8.50    PHIHH =  -163.2    ==> JHH =   8.89 
 
TEMP SET                   298 
            JEXP   JCAL   JDIF 
   1'-2'    1.40   1.33    .07 
   2'-3'    5.00   5.11   -.11 
   3'-4'    8.60   8.63   -.03 
X(1)X(2)     .68    .32   .079 
 
ROOT MEAN SQUARE DEVIATION OF THE FIT:      .079 
 
 
FIT   3 OBS TO   3 PARS -> ERROR ANALYSIS OMITTED 
 
END OF THE PROGRAM PSEUROT 6.0 
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6.2.5 2'-Methylthio-Deoxyuridine 
Trial 1 Input 
 
::"SMe, trial 1, electronegativity from table V B" 
 
SMe_database_parameters 
ctrl  maxit 25  trim 0.1  rcnv 0.5  print 1 
data 3 
1'-2'      -144.0       1.102    123.3       0.56      1.26      0.7      0.62 
2'-3'         0.0       1.090      0.2       0.62      0.7      1.26      0.62 
3'-4'       144.0       1.095   -124.9       0.62      1.26      1.26      0.68 
tset 1 
298       8.3  5.7  2.83 
start  18.0      32.0     153.6      35.0   .20 
fitf 10101 
 
Trial 1 Output 
 
SMe_database_parameters                                                          
MAXIMUM NUMBER OF ITERATIONS 25 REACHED. 
 
=============================================================================== 
 F I N A L   O U T P U T                                                      
=============================================================================== 
Total number of iterations: 25 
 
CONFORMER I:                             CONFORMER II: 
 
      P ==   -22.5  ( -.393 RAD)             P ==   138.7  ( 2.421 RAD) 
   PHIM ==    32.0  (  .559 RAD)          PHIM ==    35.0  (  .611 RAD) 
 
  PHIHH =    89.0    ==> JHH =    .69    PHIHH =   161.7    ==> JHH =  10.08 
  PHIHH =    32.4    ==> JHH =   6.46    PHIHH =   -28.5    ==> JHH =   5.52 
  PHIHH =  -143.2    ==> JHH =   6.12    PHIHH =  -116.5    ==> JHH =   2.06 
 
TEMP SET                   298 
            JEXP   JCAL   JDIF 
   1'-2'    8.30   8.30    .00 
   2'-3'    5.70   5.70    .00 
   3'-4'    2.83   2.83    .00 
X(1)X(2)     .19    .81   .000 
 
ROOT MEAN SQUARE DEVIATION OF THE FIT:      .000 
 
 
FIT   3 OBS TO   3 PARS -> ERROR ANALYSIS OMITTED 
 
END OF THE PROGRAM PSEUROT 6.0 
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Trial 2 Input 
 
::"SMe, trial 2, predominately S starting cond" 
 
SMe_database_parameters_predom_S 
ctrl  maxit 25  trim 0.1  rcnv 0.5  print 1 
data 3 
1'-2'      -144.0       1.102   123.3       0.56      1.26      0.7      0.62 
2'-3'         0.0       1.090    0.2       0.62      0.7      1.26      0.62 
3'-4'       144.0       1.095   -124.9       0.62      1.26      1.26      0.68 
tset 1 
298       8.3  5.8  2.8 
start  18.0      32.0     153.6      35.0   .80 
fitf 10101 
 
Trial 2 Output 
 
SMe_database_parameters_predom_S                                                 
MAXIMUM NUMBER OF ITERATIONS 25 REACHED. 
 
=============================================================================== 
 F I N A L   O U T P U T                                                      
=============================================================================== 
Total number of iterations: 25 
 
CONFORMER I:                             CONFORMER II: 
 
      P ==   -30.8  ( -.538 RAD)             P ==   136.9  ( 2.390 RAD) 
   PHIM ==    32.0  (  .559 RAD)          PHIM ==    35.0  (  .611 RAD) 
 
  PHIHH =    88.2    ==> JHH =    .67    PHIHH =   161.6    ==> JHH =  10.07 
  PHIHH =    30.2    ==> JHH =   6.65    PHIHH =   -27.7    ==> JHH =   5.60 
  PHIHH =  -138.7    ==> JHH =   5.38    PHIHH =  -117.6    ==> JHH =   2.20 
 
TEMP SET                   298 
            JEXP   JCAL   JDIF 
   1'-2'    8.30   8.30    .00 
   2'-3'    5.80   5.80    .00 
   3'-4'    2.80   2.80    .00 
X(1)X(2)     .19    .81   .000 
 
ROOT MEAN SQUARE DEVIATION OF THE FIT:      .000 
 
 
FIT   3 OBS TO   3 PARS -> ERROR ANALYSIS OMITTED 
 
END OF THE PROGRAM PSEUROT 6.0 
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6.2.6 2'-Selenomethyl-Deoxyuridine 
 
Trial 1 Input 
 
::"SeMe, trial 1, the electronegativity for S from table V B used, since it was an extra- 
::polated value and the Pauling negativity of S and Se only differ by 0.03. The Pauling 
::scale is broader than the Altona scale, which is used here and is correlated to coup- 
::ling constants 
 
SeMe_database_parameters 
ctrl  maxit 25  trim 0.1  rcnv 0.5  print 1 
data 3 
1'-2'      -144.0       1.102   123.3       0.56      1.26      0.68      0.62 
2'-3'         0.0       1.090    0.2       0.62      0.68      1.26      0.62 
3'-4'       144.0       1.095   -124.9       0.62      1.26      1.26      0.68 
tset 1 
298       8.65  5.7  2.86 
start  18.0      32.0     153.6      35.0   .20 
fitf 10101 
 
Trial 1 Output 
 
SeMe_database_parameters                                                         
MAXIMUM NUMBER OF ITERATIONS 25 REACHED. 
 
=============================================================================== 
 F I N A L   O U T P U T                                                      
=============================================================================== 
Total number of iterations: 25 
 
CONFORMER I:                             CONFORMER II: 
 
      P ==   -14.8  ( -.258 RAD)             P ==   137.6  ( 2.402 RAD) 
   PHIM ==    32.0  (  .559 RAD)          PHIM ==    35.0  (  .611 RAD) 
 
  PHIHH =    90.4    ==> JHH =    .72    PHIHH =   161.6    ==> JHH =  10.11 
  PHIHH =    33.9    ==> JHH =   6.37    PHIHH =   -28.0    ==> JHH =   5.58 
  PHIHH =  -147.1    ==> JHH =   6.74    PHIHH =  -117.2    ==> JHH =   2.15 
 
TEMP SET                   298 
            JEXP   JCAL   JDIF 
   1'-2'    8.65   8.65    .00 
   2'-3'    5.70   5.70    .00 
   3'-4'    2.86   2.86    .00 
X(1)X(2)     .16    .84   .000 
 
ROOT MEAN SQUARE DEVIATION OF THE FIT:      .000 
 
 
FIT   3 OBS TO   3 PARS -> ERROR ANALYSIS OMITTED 
 
END OF THE PROGRAM PSEUROT 6.0 
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Trial 2 Input 
 
::"SeMe, trial 2, starting predom S" 
 
SeMe_database_parameters_predom_S 
ctrl  maxit 25  trim 0.1  rcnv 0.5  print 1 
data 3 
1'-2'      -144.0       1.102   123.3       0.56      1.26      0.68      0.62 
2'-3'         0.0       1.090    0.2       0.62      0.68      1.26      0.62 
3'-4'       144.0       1.095   -124.9       0.62      1.26      1.26      0.68 
tset 1 
298       8.6  5.7  2.9 
start  18.0      32.0     153.6      35.0   .80 
fitf 10101 
 
Trial 2 Output 
 
SeMe_database_parameters_predom_S                                                
MAXIMUM NUMBER OF ITERATIONS 25 REACHED. 
 
=============================================================================== 
 F I N A L   O U T P U T                                                      
=============================================================================== 
Total number of iterations: 25 
 
CONFORMER I:                             CONFORMER II: 
 
      P ==   -13.3  ( -.233 RAD)             P ==   137.6  ( 2.402 RAD) 
   PHIM ==    32.0  (  .559 RAD)          PHIM ==    35.0  (  .611 RAD) 
 
  PHIHH =    90.8    ==> JHH =    .73    PHIHH =   161.6    ==> JHH =  10.11 
  PHIHH =    34.1    ==> JHH =   6.35    PHIHH =   -28.0    ==> JHH =   5.58 
  PHIHH =  -147.7    ==> JHH =   6.85    PHIHH =  -117.2    ==> JHH =   2.15 
 
TEMP SET                   298 
            JEXP   JCAL   JDIF 
   1'-2'    8.60   8.60    .00 
   2'-3'    5.70   5.70    .00 
   3'-4'    2.90   2.90    .00 
X(1)X(2)     .16    .84   .000 
 
ROOT MEAN SQUARE DEVIATION OF THE FIT:      .000 
 
 
FIT   3 OBS TO   3 PARS -> ERROR ANALYSIS OMITTED 
 
END OF THE PROGRAM PSEUROT 6.0 
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6.3 Appendix C - Compiled Matlab Results 
6.3.1 2'-Deoxyuridine 
 
//////////////////////////////////////////////////////////////  
 
  START Pseudorotational calculation  
 
//////////////////////////////////////////////////////////////  
Local minimum possible. Constraints satisfied. 
 
No active inequalities. 
 
--------------------------------------------------------------  
  Optimized parameters  
--------------------------------------------------------------  
 
   Conformation 1       
    P     :    2.314       
    Phi_m :   33.513       
 
   Conformation 2       
    P     :  149.771       
    Phi_m :   22.999       
 
   Temperature Coefficients  
    %Conformation1  :   34.682 
  
  
--------------------------------------------------------------  
  Endocyclic torsion angles 
--------------------------------------------------------------  
 Conf.1 Conf.2 
Phi0: 33.500 -19.602 
   
Phi1: -27.455 8.793 
   
Phi2: 10.924 5.374 
   
Phi3: 9.781 -17.489 
   
Phi4: -26.749 22.924 
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--------------------------------------------------------------  
  Final couplings 
--------------------------------------------------------------  
 
   Temperature 1: 
    ------------------------------------ 
    Conf1  Conf2    Avg.   Exp.  Diff. 
    ------------------------------------ 
     7.70   6.92   7.19   7.19   -0.00  
     0.99   8.88   6.14   6.14    0.00  
     6.84   6.93   6.90   6.90    0.00  
     9.64   0.84   3.89   3.89   -0.00  
     7.71   1.87   3.89   3.89   -0.00  
    ------------------------------------ 
    RMSD :     0.00 Hz 
 
 
--------------------------------------------------------------  
  ERROR ANALYSIS 
--------------------------------------------------------------  
 
  i       dP1/dPi     dP2/dPi     dP3/dPi     dP4/dPi     dP5/dPi    dRMSD/dPi  
  1        1.000      -0.704       0.566       0.380       0.405       0.015  
  2       -0.625       1.000      -0.415      -0.470      -0.485       0.015  
  3        1.267      -0.955       1.000       0.531       0.574       0.021  
  4        1.294      -1.724       0.745       1.000       1.038       0.025  
  5        1.272      -1.677       0.745       0.949       1.000       0.023  
 
  i       dP1/dCi     dP2/dCi     dP3/dCi     dP4/dCi     dP5/dCi    dRMSD/dCi  
  1       80.440     -34.693      73.888      35.526      56.410       0.017  
  2       95.746     -37.006      34.880      46.578      64.161       0.024  
  3       -9.106     -27.014     -23.388      14.642      27.562       0.058  
  4       62.868     -38.223      32.906      51.052      66.891       0.067  
  5      119.476     -38.679      25.426      74.002      87.071       0.153  
 
--------------------------------------------------------------  
  RMSD                :       0.00 Hz 
  Total time          :       0.92 s 
-------------------------------------------------------------- 
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6.3.2 Uridine 
//////////////////////////////////////////////////////////////  
 
  START Pseudorotational calculation  
 
//////////////////////////////////////////////////////////////  
//////////////////////////////////////////////////////////////  
 
 
Local minimum possible. Constraints satisfied. 
 
No active inequalities. 
 
 
--------------------------------------------------------------  
  Optimized parameters  
--------------------------------------------------------------  
 
   Conformation 1       
    P     :  169.600       
    Phi_m :   30.892       
 
   Conformation 2       
    P     :   46.669       
    Phi_m :   39.158       
 
   Temperature Coefficients  
    %Conformation1  :   43.120 
  
--------------------------------------------------------------  
  Endocyclic torsion angles 
--------------------------------------------------------------  
 
 
        Conf.1 Conf.2 
   Phi0: -30.377 27.327 
   Phi1: 21.043 -38.670 
   Phi2:  -3.671 35.242 
   Phi3: -15.103 -18.353 
   Phi4: 28.108 -5.546 
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--------------------------------------------------------------  
  Final couplings 
--------------------------------------------------------------  
 
    Temperature 1: 
 
    ------------------------------------ 
    Conf1  Conf2    Avg.   Exp.  Diff. 
    ------------------------------------ 
     7.47   2.21   4.48   4.48    0.00  
     5.31   5.29   5.30   5.30    0.00  
     0.81   9.05   5.50   5.50    0.00  
    ------------------------------------ 
    RMSD :     0.00 Hz 
 
 
--------------------------------------------------------------  
  ERROR ANALYSIS 
--------------------------------------------------------------  
 
  i       dP1/dPi     dP2/dPi     dP3/dPi     dP4/dPi     dP5/dPi    dRMSD/dPi  
  1        1.000       0.258       0.510      -0.572       0.130      -0.000  
  2       -2.615       1.000      -0.487      -1.127       0.692      -0.000  
  3        4.238      -2.681       1.000       2.197      -1.283      -0.000  
  4       -0.990      -0.697      -0.633       1.000      -0.371      -0.000  
  5        0.875       2.444       2.116      -4.800       1.000      -0.000  
 
  i       dP1/dCi     dP2/dCi     dP3/dCi     dP4/dCi     dP5/dCi    dRMSD/dCi  
  1      -49.798       7.518       3.679     -25.782      20.703      -0.000  
  2      -43.109      26.474      14.908     -18.933      23.287      -0.000  
  3     -117.997       2.186    -112.890     -10.375      30.681      -0.000  
 
--------------------------------------------------------------  
  RMSD                :       0.00 Hz 
  Total time          :       0.84 s 
-------------------------------------------------------------- 
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6.3.3 2-Methoxy-Uridine 
% Electronegativities from ribose template 
 
//////////////////////////////////////////////////////////////  
 
  START Pseudorotational calculation  
 
//////////////////////////////////////////////////////////////  
//////////////////////////////////////////////////////////////  
 
 
Local minimum possible. Constraints satisfied. 
 
No active inequalities. 
 
 
--------------------------------------------------------------  
  Optimized parameters  
--------------------------------------------------------------  
 
   Conformation 1       
    P     :   34.355       
    Phi_m :   35.492       
 
   Conformation 2       
    P     :  162.726       
    Phi_m :   30.917       
 
   Temperature Coefficients  
    %Conformation1  :   60.233 
  
--------------------------------------------------------------  
  Endocyclic torsion angles 
--------------------------------------------------------------  
 
 
            Conf.1       Conf.2  
   Phi0:     29.646      -29.463 
   Phi1:    -35.545       18.187 
   Phi2:     27.867        0.036 
   Phi3:     -9.545      -18.245 
   Phi4:    -12.423       29.485 
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--------------------------------------------------------------  
  Final couplings 
--------------------------------------------------------------  
 
   Temperature 1: 
 
    ------------------------------------ 
    Conf1  Conf2    Avg.   Exp.  Diff. 
    ------------------------------------ 
     1.43   7.70   3.92   3.92   -0.00  
     5.08   5.38   5.20   5.20    0.00  
     8.75   0.98   5.66   5.66   -0.00  
    ------------------------------------ 
    RMSD :     0.00 Hz 
 
 
--------------------------------------------------------------  
  ERROR ANALYSIS 
--------------------------------------------------------------  
 
  i       dP1/dPi     dP2/dPi     dP3/dPi     dP4/dPi     dP5/dPi    dRMSD/dPi  
  1        1.000       0.077       2.257       0.175       0.140      -0.000  
  2        0.583       1.000       0.144      -0.933      -0.531      -0.000  
  3        0.505       0.128       1.000      -0.031       0.014      -0.000  
  4       -0.386      -0.827      -0.242       1.000       0.528      -0.000  
  5       -0.088      -1.393       0.585       1.899       1.000      -0.000  
 
  i       dP1/dCi     dP2/dCi     dP3/dCi     dP4/dCi     dP5/dCi    dRMSD/dCi  
  1       -2.051      -3.778     -31.546      13.493      -1.151      -0.000  
  2       12.264      -0.758     -29.187     -18.272     -10.879      -0.000  
  3        2.090      -7.188     -27.318      22.130      19.079      -0.000  
 
--------------------------------------------------------------  
  RMSD                :       0.00 Hz 
  Total time          :       0.63 s 
--------------------------------------------------------------  
 
 
  
43 
6.3.4 2'-Fluoro-Deoxyuridine 
%Electronegativity position 9 changed to 1.37, rest of values taken from rU template 
 
//////////////////////////////////////////////////////////////  
 
  START Pseudorotational calculation  
 
//////////////////////////////////////////////////////////////  
//////////////////////////////////////////////////////////////  
 
 
Local minimum possible. Constraints satisfied. 
 
No active inequalities. 
 
 
--------------------------------------------------------------  
  Optimized parameters  
--------------------------------------------------------------  
 
   Conformation 1       
    P     :   36.089       
    Phi_m :   34.186       
 
   Conformation 2       
    P     :   38.134       
    Phi_m :   34.176       
 
   Temperature Coefficients  
    %Conformation1  :   96.888 
  
--------------------------------------------------------------  
  Endocyclic torsion angles 
--------------------------------------------------------------  
 
 
            Conf.1       Conf.2  
   Phi0:     27.968       27.945 
   Phi1:    -34.265      -34.256 
   Phi2:     27.474       27.482 
   Phi3:    -10.189      -10.211 
   Phi4:    -10.988      -10.960 
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--------------------------------------------------------------  
  Final couplings 
--------------------------------------------------------------  
 
   Temperature 1: 
 
    ------------------------------------ 
    Conf1  Conf2    Avg.   Exp.  Diff. 
    ------------------------------------ 
     1.41   1.41   1.41   1.38    0.03  
     4.95   4.95   4.95   4.99   -0.05  
     8.61   8.61   8.61   8.63   -0.02  
    ------------------------------------ 
    RMSD :     0.03 Hz 
 
 
--------------------------------------------------------------  
  ERROR ANALYSIS 
--------------------------------------------------------------  
 
  i       dP1/dPi     dP2/dPi     dP3/dPi     dP4/dPi     dP5/dPi    dRMSD/dPi  
  1        1.000       0.090      -0.015      -0.003     -18.504       0.000  
  2        1.282       1.000      -0.013      -0.003     -18.504       0.000  
  3        0.001       0.000       1.000      -0.292       0.594       0.000  
  4        0.000      -0.000      -0.156       1.000       0.594      -0.000  
  5        0.000       0.000       0.000       0.000       1.000       0.000  
 
  i       dP1/dCi     dP2/dCi     dP3/dCi     dP4/dCi     dP5/dCi    dRMSD/dCi  
  1       20.139      17.336     -15.031      36.082     -33.861      -0.034  
  2        4.987      -2.483       4.526       1.499       5.519       0.233  
  3        6.661       7.601       6.566      -7.616     -20.497       0.126  
 
--------------------------------------------------------------  
  RMSD                :       0.03 Hz 
  Total time          :       0.39 s 
--------------------------------------------------------------  
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6.3.5 2’-Methylthio-Deoxyuridine 
%Electronegativity at position 9 changed to 0.785, literature results for –SR group;  
%rest of values from ribose template 
 
//////////////////////////////////////////////////////////////  
 
  START Pseudorotational calculation  
 
//////////////////////////////////////////////////////////////  
//////////////////////////////////////////////////////////////  
 
 
Local minimum possible. Constraints satisfied. 
 
No active inequalities. 
 
 
--------------------------------------------------------------  
  Optimized parameters  
--------------------------------------------------------------  
 
   Conformation 1       
    P     :   50.661       
    Phi_m :   16.656       
 
   Conformation 2       
    P     :  127.057       
    Phi_m :   45.098       
 
   Temperature Coefficients  
    %Conformation1  :   23.584 
  
--------------------------------------------------------------  
  Endocyclic torsion angles 
--------------------------------------------------------------  
 
 
          Conf.1 Conf.2 
   Phi0:  -14.440 -26.741 
   Phi1:  6.756 0.209 
   Phi2:  3.509 26.402 
   Phi3:  -12.433 -42.929 
   Phi4:   16.609 43.058 
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--------------------------------------------------------------  
  Final couplings 
--------------------------------------------------------------  
 
   Temperature 1: 
 
    ------------------------------------ 
    Conf1  Conf2    Avg.   Exp.  Diff. 
    ------------------------------------ 
     5.29   9.19   8.27   8.27    0.00  
     6.31   5.63   5.79   5.79    0.00  
     2.12   3.05   2.83   2.83   -0.00  
    ------------------------------------ 
    RMSD :     0.00 Hz 
 
 
--------------------------------------------------------------  
  ERROR ANALYSIS 
--------------------------------------------------------------  
 
  i       dP1/dPi     dP2/dPi     dP3/dPi     dP4/dPi     dP5/dPi    dRMSD/dPi  
  1        1.000       0.011      -0.083       0.058       0.004       0.000  
  2        0.094       1.000       0.248      -0.397      -0.850       0.000  
  3      -15.075       2.266       1.000      -1.537      -2.494       0.000  
  4        2.079      -1.816      -1.040       1.000       2.002       0.000  
  5       -0.108      -0.922      -0.319       0.451       1.000       0.000  
 
  i       dP1/dCi     dP2/dCi     dP3/dCi     dP4/dCi     dP5/dCi    dRMSD/dCi  
  1       19.438      30.222       3.961      -9.581     -47.169       0.024  
  2       -9.868     -13.068       3.034     -18.964     -47.169       0.206  
  3       32.779      20.861      -7.126       9.082      -7.419       0.000  
 
--------------------------------------------------------------  
  RMSD                :       0.00 Hz 
  Total time          :       0.56 s 
--------------------------------------------------------------  
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6.3.6 2'-Selenomethyl-Deoxyuridine 
%Electronegativity for 2' from Manual, rest of values from ribose template 
 
//////////////////////////////////////////////////////////////  
 
  START Pseudorotational calculation  
 
//////////////////////////////////////////////////////////////  
//////////////////////////////////////////////////////////////  
 
 
Local minimum possible. Constraints satisfied. 
 
No active inequalities. 
 
 
--------------------------------------------------------------  
  Optimized parameters  
--------------------------------------------------------------  
 
   Conformation 1       
    P     :    7.165       
    Phi_m :   20.308       
 
   Conformation 2       
    P     :  134.686       
    Phi_m :   40.370       
 
   Temperature Coefficients  
    %Conformation1  :   17.768 
  
--------------------------------------------------------------  
  Endocyclic torsion angles 
--------------------------------------------------------------  
 
          Conf.1 Conf.2 
   Phi0:  20.231 -25.056 
   Phi1:  -17.695 5.558 
   Phi2:  8.401 19.064 
   Phi3:  4.103 -36.404 
   Phi4:   -15.039 39.839 
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--------------------------------------------------------------  
  Final couplings 
--------------------------------------------------------------  
 
   Temperature 1: 
 
    ------------------------------------ 
    Conf1  Conf2    Avg.   Exp.  Diff. 
    ------------------------------------ 
     1.62  10.17   8.65   8.65   -0.00  
     7.00   5.44   5.72   5.72    0.00  
     6.05   2.17   2.86   2.86   -0.00  
    ------------------------------------ 
    RMSD :     0.00 Hz 
 
 
--------------------------------------------------------------  
  ERROR ANALYSIS 
--------------------------------------------------------------  
 
  i       dP1/dPi     dP2/dPi     dP3/dPi     dP4/dPi     dP5/dPi    dRMSD/dPi  
  1        1.000       0.026       0.095      -0.062       0.004       0.000  
  2        0.247       1.000       0.181      -0.416      -0.280      -0.000  
  3        6.647       4.577       1.000      -1.557      -0.903       0.000  
  4       -0.533      -1.967      -0.497       1.000       0.616       0.000  
  5        2.274      -2.911      -0.592       1.435       1.000      -0.000  
 
  i       dP1/dCi     dP2/dCi     dP3/dCi     dP4/dCi     dP5/dCi    dRMSD/dCi  
  1      -19.912     -59.176     -18.903      25.203      20.176       0.000  
  2        6.555     -36.335     -11.634      -7.149      -1.509      -0.000  
  3       39.923      14.556      -4.233       1.885       2.324       0.000  
 
--------------------------------------------------------------  
  RMSD                :       0.00 Hz 
  Total time          :       0.67 s 
-------------------------------------------------------------- 
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7 INTRODUCTION 
7.1 The Central Dogma of Molecular Biology 
The complexity of the living world is governed, maintained and perpetuated by a 
fairly simple process that is conserved from bacteria to humans. This flow of information 
is so critical to the function of biological processes and the understanding of the 
concepts involved that it is designated the central dogma of molecular biology.1 The 
genetic code, the series of chemical bytes that contains the information needed for 
construction of a living entity, consists of DNA. This biological polymer is characterized 
by a phosphate-linked chain of sugars attached to a planar moiety called a nucleic 
base. This base is the information carrier and a group of three bases encodes a specific 
amino acid. A DNA polymer is very long, contained as a chromosome within an 
organism‟s genome. These chromosomes are safe-guarded during normal cellular 
operation and replicated when a cell is dividing during growth. Segments of the 
chromosome, called genes, are accessed and transcribed into shorter, similar oligomers 
consisting of RNA. These messenger RNAs contain the blueprint for a protein as 
encoded by the DNA and through the action of ribosomes (large protein/ RNA 
complexes) the signal is translated into a second type of biopolymer, a protein. A 
simplified picture of these processes is shown in Figure 7.1.   
There are viruses whose replication cycle is dependent on reverse transcription 
of RNA to DNA or the replication of RNA, and some eukaryotic processes such as 
telomere elongation or RNA interference use similar mechanisms.2-3 The general case, 
however, of DNA transcription to RNA then translation to a protein is the most common 
sequence of events.  
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7.2 Protein Chemistry and Structure 
Perhaps the most awe-inspiring concept in biochemistry is the ability of roughly 
20 building blocks to combine to form structures that can catalyze reactions, bind 
substrates, recognize threats, and transport nutrients with such specificity and diversity. 
Proteins are known as the workhorses of a cell, building and degrading all major 
components while transporting and proofreading unfinished products under highly-tuned 
regulation. The populations and chemical properties of the amino acid building blocks 
within the peptide-bond linked polymers are that which gives rise to this diversity of form 
and function. 
The amino acids themselves are built on the same form, consisting of a 
carboxylic acid and an amine linked to a carbon atom that also contains an additional 
functional group, the identity of which determines the identity of the amino acid. The 
stereochemistry of the α-carbon (the atom to which the amine, carboxylic acid, and 
functional group are attached) can be either D- or L- in the convention of chirality, but 
interestingly only L-amino acids are utilized in biological systems for protein synthesis. 
Proteins, when compared to other biological polymers, are much more diverse in 
Figure 7.1 Central Dogma of Molecular Biology 
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function because the side chains of these amino acid monomers can range from acidic 
to basic, polar to non-polar, and aromatic to aliphatic. In a cell, functional proteins are 
able to happily perform their roles based on this assortment of choices for building 
blocks.  
The proper arrangement of these building blocks has a large effect on the 
function of a protein, and naturally on the overall structure. Many forces play in the 
folding of a long polypeptide into a functional protein, mainly hydrophobic interactions 
directing non-polar residues away from the water solvent and align the side chains in a 
relatively high density.4 Secondary structural elements of a protein are often 
characterized by patterns in the sequence, as an alternation between polar and non-
polar amino acids can contribute to the formation of an α-helix or β-sheet depending on 
the pattern. These secondary structure components put the appropriate amino acids 
that are not necessarily close in sequence near to each other in space allowing for a 
protein to be active. In addition, in eukaryotic proteins, a degree of post-translational 
modification (e.g. methylation, acetylation, glycosylation) is necessary for correct 
function. 
7.3 Diversity in Environment and Function 
Life inhabits a great majority of the surface of the earth, and because of these 
drastically different environments there is an even wider range of metabolic diversity. 
Phototrophs, nitrogen-fixers, hydrogen sulfide oxidizers, anaerobes, and methanophiles 
all use specific proteins to accomplish the continuous act of using energy. These 
proteins are usually specific in their action as well as optimized for the conditions.  
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The action of a protein is usually concentrated in a specific subspace of a cell or 
tissue. This is easy to accept when considering the ineffectiveness of a transcription 
factor embedded into the plasma membrane or cardiac myosin fibers forming in the 
pituitary gland. The inherent need for a tightly regulated transport system is clear, and 
nature utilizes two broad categories of protein targeting: Co-translational and post-
translational, which are visualized in Figure 7.2. Initiation of translation occurs but when 
the nascent peptide emerges from the ribosomal tunnel, the pathways diverge. The co-
translational transport pathway is initiated like normal protein synthesis but is paused 
while a chaperone directs the ribosome to the cell membrane and the protein is inserted 
into the cell membrane or the periplasm. The action of membrane translocation is 
usually coupled with GTP hydrolysis.5 In contrast, as the name implies, the post-
translational mechanism occurs after translation. A different signal sequence is 
contained within a post-translationally transported protein and is directed to one of many 
locations within the cell such as the periplasm in gram negative bacteria or various 
organelles within eukaryotes. An interesting correlation between the two processes is 
the hallmark of post-translational transport: a fairly conserved set of ATP binding 
components to shuttle proteins across membranes like SecA in prokaryotes and 
HSP70, HSP40 and ASNA1 in eukaryotes.5 A main feature of the transport factors in 
both cases is centered on assuring the continuance of a translation competent state, in 
the sense of assurance that the fresh peptide chains do not fold too early or aggregate 
with other cellular components. Proteins that do not have a signal sequence fold into 
their active states and usually remain in the cytoplasm.  
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7.4 Commercial Protein Production and the Perspective of this Manuscript 
The diversity of protein function inevitably leads to a large economic value for 
certain proteins that can perform a specific task. Digestive enzymes are critical for 
paper, detergent, food, and fuel industries. Antibodies, hormones, and biopolymer 
building blocks are relevant in medicine. As the world becomes more advanced 
Figure 7.2 Co and Post-Translational Secretion Mechanisms. Co-translational transport 
begins with a pause in translation (1) and direction of the ribosome to the cell membrane (2). 
Translation continues and the peptide is directed into the periplasm (3) or the cell membrane 
itself. Post-translational Protein Transport does not pause translation (A) and the signal 
sequence is recognized after translation occurs (B), with the newly synthesized peptide being 
exported across the membrane upon sequence recognition (C). 
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technologically, the demand for these and other biologically based products will only 
increase. Industries use different organisms to make the intended products, often in a 
recombinant fashion where the protein is produced in a species different from where it is 
naturally found, and current protocols have been effective in the manufacturing of 
acceptable amounts of various products. Still, each method is a culmination of many 
attempts to find optimum conditions at a scale that is economically suitable. 
There has been a push more recently to try and develop more effective protein 
production systems,6-7 where purification can be simpler while increasing yields without 
significantly altering the growth cycles of the cultures. One of the more realistic ways of 
achieving these goals is to use secretion platforms to transport proteins of interest 
outside of the cell, away from the majority of cellular components that can contaminate 
and degrade the recombinant products. If the protein is secreted, then the purification 
process is greatly simplified by not separating out the entire proteome within the cell, as 
is the case with intracellular expression and lysis. The direction of proteins out of a cell 
allows for them to be drained away in a reactor during the cycling of nutrients and 
purified afterwards in fewer steps. This approach is also appealing because the cultured 
cells would not need to be lysed in order to retrieve the products and could remain in an 
induced production state.    
This paper is an attempt to distill relevancy and perspective from the vast amount 
of information available about protein production and secretion, including current and 
future applications, while directing interested parties towards further research. 
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8 PROKARYOTIC PROTEIN EXPORT 
8.1 Prokaryotic Cell Biology 
Prokaryotes (bacteria, archaea) are the simplest forms of life while genetically 
and metabolically the most diverse. These single-celled creatures are robust and highly 
specialized, which contributes to their diversity. A generalized model of both domains 
depicts the prokaryotic cell as a living soap bubble. The DNA, RNA, and proteins within 
the cell are all exposed to each other in a mixture of metabolites and salt. The genetic 
material is constantly being transcribed and translated into its encoded products 
surrounded by a lipid bilayer (at least one, and possibly by a cell wall) that keeps the 
cell‟s contents separate from the extracellular medium from which sustenance and 
stimuli are sourced. The cell membrane is spotted with proteins that form channels for 
the maintenance of cellular homeostasis and receptors for a variety of substrates that 
the cell deems worthy of engulfing or avoiding. The ribosomes that translate the mRNA 
into proteins are free in the cytoplasm, which allows for quick responses to stimuli, but 
still requires a system of organization for controlling this process. 
The vast array of different metabolic pathways utilized by bacteria is far beyond 
the scope of this paper, but it is worth knowing that the mechanism for energy 
consumption that a prokaryote employs because of the high level of regulation involved 
in different periods of metabolic functioning. Times of starvation cause the activation of 
certain genes and the repression of others, while times of abundant resources have the 
opposite effect. Normal functioning requires regulation as well. Prokaryotes do not have 
compartmentalized organelles but do contain localizing signal sequences that direct 
membrane or periplasm proteins to their appropriate places. Extracellular proteins are 
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directed outside by several secretion systems, but the degree to which this happens 
depends on the species. For example, heterotrophic organisms would be expected to 
secrete digestive enzymes to obtain energy containing compounds, while phototrophic 
microbes would not need to export proteins as their energy comes from light and their 
carbon source is atmospheric CO2.  
8.2 Prokaryotic Secretion Mechanisms 
8.2.1 Type I Secretion 
Gram negative bacteria have a harder time exporting protein than gram positive 
because their additional LPS-containing outer membrane is an extra step in the 
process. The type I secretion system (T1SS) is one mechanism gram negative bacteria 
use to overcome this barrier. T1SS is composed of three proteins located in the cell 
membranes, each of which is required for secretion. T1SS allows for the secretion of 
proteins of various sizes and functions from the cytoplasm to the extracellular medium 
in a single step. The process begins with recognition of a C-terminal, glycine-rich signal 
sequence by an ATP-binding cassette (ABC) protein. The exact sequence of the signal 
varies between target proteins and bacteria species. A general consensus is a repeat of 
GGXGXDXXX, from a few to more than 50 repeats depending on the protein and 
species. This segment is almost always acidic and can bind calcium specifically. The 
ABC protein is bound to a membrane fusion protein (MFP) which in turn is linked to an 
outer membrane protein (OMP). This complex modulates the opening and closing of a 
tunnel through both membranes allowing the protein to transverse, and all three of the 
components are required for secretion to occur. This mechanism is reviewed in a step-
wise process by Delepelaire8 quite effectively. A general scheme of the T1SS is shown 
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in Figure 8.1. One of the more widely studied examples of a T1SS is the hemolysin A 
pathway, a protein secreted by pathogenic bacteria such as E. coli and S. aureus that 
lyses red blood cells and binds free iron. Hemolysin A (HlyA) is the name of the 46-60 
amino acid signal sequence in E. coli, and it is recognized by HlyB and HlyD before 
being exported by TolC,9 the OMP for the HlyA pathway and many others. This pathway 
is popular because of its simplicity and capability of transporting large (up to 800 kDa) 
proteins through its 20-30 Å pore, but is naturally only capable of yields in the 10mg/ L 
range.10 
Figure 8.1 Mechanism of protein export by T1SS. (1) C-terminal signal sequence is 
recognized by the ATP-binding cassette (ABC) while chaperone proteins keep the polypeptide 
unfolded. (2) ABC forms complex with the membrane fusion protein (MFP) and outer 
membrane protein (OMP) while binding ATP. (3) ATP hydrolysis drives the opening of the 
channel and the secretion of the protein. Figure adapted from Delepelaire8. 
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T1SSs have been demonstrated to export a wide range of proteases, lipases and 
adhesins in wild-type gram negative bacteria, as well as a reasonable amount of 
recombinant fusion proteins. The signal sequence itself has been examined using a 
systems biology approach, basically assuming DNA encoding glycine rich residues 
upstream of stop codons correlate to T1S signal sequences.9 The beauty of the T1SS is 
that it can send a peptide across both cellular membranes in a single step,11 however 
undesired translation rates must be kept to a minimum in order to avoid clogging the 
machinery.12 
8.2.2 Type II Secretion 
The second type of secretion mechanism characterized in gram negative 
bacteria, the aptly named Type II secretion system (T2SS), proceeds via a two step 
process, in contrast to T1S. The first step is translocation across the inner membrane 
and an amount of time residing in the periplasmic space. The second step is secretion 
from the periplasm to the exterior of the cell. The molecular machinery that executes the 
first step of the T2S process is a fairly complicated structure. A review of 12 different 
genera by Cianciotto elegantly compiles the conserved elements and describes their 
functions.13 There are three related mechanisms by which T2S can be executed: The 
Sec-dependent pathway, a signal recognition particle (SRP) pathway, or the twin-
arginine translocase (TAT) pathway.9 Each of these pathways has their own versions of 
pseudopilins, which facilitate the binding of the ATPase attachment to the inner 
membrane and form the pore through the membrane. The pathways also include the 
secretin pore, which forms upon the congregation of secretin monomers in the outer 
membrane, and a protein involved in substrate recognition.13 
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The Sec pathway is a post-translational secretion system. This route is directed 
by a cleavable N-terminal signal sequence that can vary with respect to the protein 
being secreted or the species involved. The protein led by the signal sequence is 
delivered to the periplasm or outer membrane and then the signal is cleaved.14 Because 
this is a post-translational mechanism, there are chaperone proteins that are known to 
interact with the unfolded region of the peptide to discourage aggregation and to 
maintain the full secretory proficiency. SecB is the most common chaperone in the Sec 
pathway, and it is interesting to note that it does not bind to the signal sequence itself; 
rather it holds extensive unfolded segments of the substrate with little specificity. The 
only known protein SecB binds with high affinity is SecA, which is associated with the 
SecYEG export channel and is believed to assist in proper delivery to the pore.5 A few 
other cytosolic chaperones that are related to heat-shock proteins of the HSP70 family 
have been reviewed by Cross et al.5 and have been well characterized as intermediates 
in protein folding and cell stress. These proteins have been shown to help recover some 
protein secretion in SecA/SecB knockout strains.15 These particular HSP70 proteins, 
DnaJ and DnaK are ubiquitous proteins in gram-negative bacteria and seem to be 
involved in Sec-independent secretion pathways as well.16 Another interesting finding 
regarding the Sec-pathway is the dependence on the amino acid flanking the signal 
sequence for efficient protein export. The study by Kaderbhai et al. indicates that 
smaller, more hydrophilic amino acids are ideal for the flanking residue.17  
The SRP pathway is a co-translational pathway facilitated by an N-terminal, 
highly hydrophobic sequence, similar to SecB, and actually uses the same translocation 
machinery (SecYEB complex) upon binding to SRP.18 The hydrophobicity of the N-
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terminal sequence determines which cofactor will bind and direct export. One can 
engineer hydrophobicity into the sequence and recruit the SRP, which tends to help 
when proteins fold too rapidly for SecB transport. A downside to this technique as a 
protein production avenue is that the proteins accumulate in the periplasm and do not 
reach significant levels outside of the cell. Ways to overcome this problem are 
discussed in Section 11.4. 
The twin-arginine translocase (TAT) pathway is independent of Sec machinery 
and ATP hydrolysis, and is characterized by the highly conserved double arginine 
segment of its signal sequence, actually using the intermembrane‟s proton motive force 
to drive export. What is interesting about the TAT pathway is that it can transport fully 
folded proteins across the inner membrane, including ones with redox cofactors. In 
silico predictions suggest that roughly 20% of secretion in Streptomyces is dependent 
on the TAT process.19 The TAT pathway has been used to moderate success for the 
production of extracellular recombinant proteins, and there have been reports of 
increased protein production upon the overexpression of TAT translocation elements.20-
21 This is promising considering the fact that wild-type TAT dependent secretion is fairly 
low in both E. coli and B. subtilis.22-23 A comparison between the different T2SSs is 
given in Figure 8.2. The evidence of the role of T2SS machinery in the pathogenesis of 
many bacteria is present in systems biology studies of the genomes of fish, mammal, 
and plant pathogens. This data is drawn from analysis of potential secretion signal 
sequences, the degradative nature of known T2SS dependent proteins, the fact that 
some mutations in T2SS genes can lower virulence in some relevant plant and animal 
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disease models, and the few instances where individual T2 exoenzymes have been 
shown to contribute to pathogenicity,13 namely cholera toxin.24 
 However, there are several instances of non-pathogenic bacteria utilizing a 
T2SS: A.calcoaceticus secretes dodecane degradative enzymes,25 A.alcaligenes 
secretes lipases,26 P.putida exports manganese and iron reducing enzymes27 similar to 
S. oneidensis,28 and G. diazotrophicus secretes a levansucrase.29 
8.2.3 Type III Secretion 
The type III secretion system family (T3SS) of protein complexes is based on a 
complicated macromolecular machine consisting of a secretion apparatus, chaperones, 
the secreted proteins themselves, and cytoplasmic regulators. Flagellar proteins are 
Figure 8.2 Comparison of T2SS mechanisms 
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often dependent on T3SS machinery, and a large portion of the proteins secreted are 
known to be involved in the virulence of pathogens that allow them to colonize a niche 
within the host, evade immune system detection, enter or exit host cells, or obtain 
nutrition.30  
The T3SS is built across the membranes and protrudes outside of the cell. It acts 
as a sensor for host contact. The assembly of the machinery begins with the formation 
of a basal body complex which spans the inner and outer bacterial membrane and acts 
as the scaffolding for needle subunits and needle length control proteins to build the 
injection apparatus. The needle subunits form a hollow extracellular structure and upon 
reaching the ideal length, a substrate switch is activated and the tip proteins form the 
completed assembly and secretion is halted until host cell contact occurs. The pore 
subunits are secreted when the pathogen makes host cell contact. They insert into the 
host membrane to form another pore and initiate the final substrate switch to begin 
secretion of virulence factors into the host cell. The mechanism of this complicated 
process is regulated at transcriptional, post-transcriptional, and translational levels and 
is dependent on the conformational switching of the components and the actual 
secretion of the building blocks.31-32 Deane et al. have reviewed this process in detail,30 
and Figure 8.3 shows a model of a mature T3S apparatus. T3S also directs proteins to 
its translocation process with a signal sequence. There has been little agreement 
regarding the nature of the signal because there is neither a cleavable sequence nor a 
recognized consensus in sequence. The exact mechanism of T3S regulation is still 
being debated, as evidence shows that the mRNA and the peptide signal sequence are 
critical in some cases while unnecessary in others.33 However, recently, a minimal, 22-
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residue sequence at the N-terminus of a flagellin molecule has been identified to 
contain all essential information to direct the protein to the T3SS. 
 Furthermore, the T3S export channel does not seem to be highly specific for the 
flagellar proteins, but is capable of exporting a variety of proteins.33 A caveat to consider 
during the construction of T3S-dependent production systems is the necessity of 
chaperone binding sites as well as a proper signal sequence, as deletion of either has 
been shown to diminish secretion.34 The pore itself is narrow (25 – 30 Å) and so 
proteins are expected to pass through in a mostly unfolded state,35 which also puts a 
constraint on the applicability of certain recombinant protein production. However, the 
Figure 8.3 Illustration of the T3SS/ Host Cell Conjugate Apparatus 
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core components of the T3SS are conserved between species,36 and data suggests that 
there are conserved targeting mechanisms as well. T3SSs from one type of bacteria 
can in some cases export proteins from another bacterial species with the foreign signal 
sequence, and some small molecule inhibitors of T3S have been shown to be effective 
across many genera.37 The consensus seems to be that the proton motive force (PMF) 
drives the translocation of peptides through the secretion apparatus in conjunction with 
ATP hydrolysis. The ATP hydrolysis only occurs when a chaperone protein comes in 
contact with an ATPase that is part of the inner membrane complex, and a 
conformational change is induced in the complex. The pH gradient is suggested at the 
carrying force, as opposed to an electronic potential difference facilitating motion, which 
means that T3S is similar to the Sec and TAT pathways in this regard.38 
8.2.4 Types IV - VII 
There are other types of secretion systems employed by prokaryotes for various 
functions, but they share similarities to the systems described above. Type IV secretion 
(T4S) is a sophisticated process, dependent on the formation of a large secretion 
platform, and is related to conjugation transfer machines that transport nucleic acid-
protein complexes between two cells. This transfer of genetic material and protein can 
occur between two species of bacteria or between bacterial pathogens and their 
hosts.39-40 The consensus is that the process transports its cargo across both 
membranes without an extended visit to the periplasm once the transport machinery 
has assembled. The models of action proposed are designated as the channel model 
and the piston model. As their name implies, in the first mechanism the pilus structure 
opens a channel and allows the proper substrate to pass through the membranes, while 
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the second mechanism has the pilus acting like a molecular piston, pushing the 
substrate through the membranes.41 
Type V secretion (T5S) has an interesting pathway. The two most studied 
variants of the T5SS are named the autotransporter complex and Twin-partner 
secretion, and both consist of a family of virulence factors that use the Sec pathway to 
enter the periplasmic space and then, via a conserved C-terminal β-domain that inserts 
into the outer membrane, serves to secrete and cleave the N-terminal passenger 
domain.42 The proposed mechanisms for this action, which are mediated by periplasmic 
chaperone proteins,43-44 can vary on the final cleavage of the passenger domain from 
the translocation domain. The autotransporter mechanism is described as the hairpin 
model and suggests that the C-terminal linker section connecting the β-domain to the 
secreted domain enters the translocation channel first and then threads the remaining 
portion of the protein through, and the folding of this secreted domain into an α-helix 
pulls the peptide through the channel. Upon the full transport and folding of the peptide, 
it can remain attached to the translocation element or can be cleaved by extracellular 
proteases. In the twin-partner secretion pathway, the translocation element and the 
secreted protein are not fused in a propeptide-like product, but are usually encoded 
within the same operon. Both types are directed to the periplasm through a T2SS 
pathway, and after the translocation element inserts into the outer membrane, it 
recognizes its partner‟s N-terminal sequence and proceeds to export it out of the cell.42 
Type VI secretion (T6S) is another secretion mechanism of gram negative 
bacteria, originally thought to be a part of T4S, but seems to only share chaperones in 
certain cases.45 After further study, the T6SS has been shown to function in some 
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capacity in quorum sensing,46-47 as well as containing components that are host 
specific.48 The data suggests that T6S is important in deciding the fate of various 
bacteria in polymicrobial environments, and it is known that the machinery resembles 
the needle apparatus common to other secretion systems, but the mechanisms and 
regulation of the T6SSs are still largely unknown.49 
Type VII secretion (T7S) has been recently identified as a unique function of 
mycobacteria, allowing them to achieve virulence as well as cell to cell communication 
through their highly hydrophobic mycolic acid membrane.50 The process is also referred 
to as the ESX pathway, and consists of a large set of proteins contained in a particular 
gene cluster. The process is very complicated, involving many transmembrane domains 
involved in recognition and guidance of apparatus assembly, some of which may be 
involved with some T4SS components, though the debate is still occurring. Although 
noted to be a critical part of certain pathogenic life cycles, such as Mycobacterium 
tuberculosis, this system has not been studied to the extent as some of the previous 
systems and the scope of its coverage will be limited here, though Simeone et al. have 
reviewed the relationship between mycobacterial T7S with host infection quite 
effectively.51 
Each of the secretion pathways discussed in this section has value for the 
microbes that employ them, however, they have not been characterized to the point of 
exhibiting potential for extracellular recombinant protein production. Figure 8.4 is 
included to highlight the similarities and differences between each type of secretion 
systems found in prokaryotes.52 
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9 EUKARYOTIC PROTEIN EXPORT 
9.1 Basic Eukaryotic Cell Biology 
The central dogma of molecular biology holds true when discussing eukaryotes 
as well as prokaryotes, the main difference between these two being a level of 
complexity in physiology. Prokaryotes are by far more diverse metabolically, but 
eukaryotes are diverse in ways visible every day. All multicellular life is contained in the 
Eukaryota domain, and they are characterized by a series of intracellular organelles, 
each with their own membrane and self-contained processes. A sketch of the 
differences between prokaryotic and eukaryotic cells is shown in Figure 9.1.53 The most 
definitive is the nucleus, which contains the genetic material of the cell and is the 
location of replication, transcription and mRNA editing. The nuclear environment is 
designed to protect the DNA from oxidative damage or foreign entities, and also 
contains the machinery for DNA repair. The mRNA synthesized in the nucleus is 
transported to the cytoplasm where signal sequences send the transcript to the 
Figure 8.4 Overview of Known Bacterial Secretion Systems. Abbreviations are as follows: 
IM – Inner Membrane, OM – Outer Membrane, OMP – Outer Membrane Protein, MFP – 
Membrane Fusion Protein, HM – Host Membrane, MM - Mycomembrane. Figure taken without 
permission from Tseng et al., 2009.52 
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endoplasmic reticulum (ER) where they are translated into proteins by membrane-
bound ribosomes. Eukaryotic protein structures are governed by the same 
intermolecular forces, and must be properly folded for function. The ER itself is a 
complex mixture of proteins that welcome incoming nascent peptides and assist in the 
folding process, consisting of a large quality control system. There are five main 
components of this system: Molecular chaperones that bind the nascent peptide until it 
can finish being translated before folding occurs, protein disulfide isomerases that 
reduce incorrectly formed disulfide bonds and allow the correct links to be connected, 
digestion machinery to process incorrectly folded proteins as part of the ER associated 
Figure 9.1 Overview of Eukaryotic Cell Biology. (Left) General comparison between 
eukaryotic and prokaryotic cell physiology. Picture from http://rst.gsfc.nasa.gov/Sect20/A12.html 
(Accessed April 10, 2011). (Right) Process of protein transport throughout a eukaryotic cell. 
Image from Xu and Esko, 2009.53 Both images used without permission. 
70 
protein degradation (ERAD), signal transduction pathways linked with this response, 
and a variety of post-translational modification enzymes involved with the final 
processing of synthesized proteins.54 
Eukaryotic cells are generally much larger than prokaryotic cells, and because of 
the complexity of these systems and their compartmentalized physiology, the ability to 
recognize a signal sequence accurately and process it properly is an evolutionary 
function that eukaryotes have mastered.  
9.2 Protein Sorting/ Targeting 
Eukaryotes are inherently more complicated systems than prokaryotes because 
of the degree of compartmentalization within the cells. As stated above, transcription 
and RNA editing occur within the nucleus of a cell, while translation occurs in the 
cytoplasm, with or without being directed to the endoplasmic reticulum/ Golgi body 
network. The direction of proteins from the ER is mediated by signal sequences in the 
proteins themselves. Membrane bound proteins are sent to their respective organelles 
by traveling through the ER and Golgi apparatus until the formation of vesicles (small 
membrane-encapsulated micelle-like structures that carry proteins and metabolites 
through the cell with the help of cytoskeletal systems) transport the vesicle to its 
appropriate location imbedded into various cellular membranes. Other non-membrane 
proteins are sent inside the organelles themselves, some are exported out of the cell, 
while others remain inside the lumen of the ER or Golgi apparatus. The exception to this 
packaging of proteins for cell subspace delivery is the proteins of mitochondria and 
chloroplasts, a fraction of which are encoded by organelle DNA and transcribed and 
translated within the membrane of the organelle. The signaling sequences used in 
71 
eukaryotes can be located at the termini of the peptides or within the internal sequence, 
and many proteins require specific chaperones to fold correctly. In addition to the high 
degree of specific transport, many outer membrane proteins of eukaryotes have large 
amounts glycosylation sites that are used in recognition and communication between 
cells and must be added to the protein after translation. With all of these steps towards 
maturity, there are several proofreading systems in place that mark misfolded or 
mistranslated proteins with ubiquitin for degradation. Figure 9.2 gives a summary of 
targeting pathways in eukaryotic cells.55 
Nevertheless, eukaryotic protein transport follows the same general pathways as 
prokaryotes: co-translational and post-translational. The co-translational is most 
effective for membrane bound proteins, as the incorporation of the nascent peptide 
directly into the membrane lowers the probability of misfolding as the large 
concentration of hydrophobic amino acids are not exposed to the aqueous environment 
of the lumen or cytoplasm and the energy of translation can drive the peptide forward. 
(See Section 8.2.2).The posttranscriptional pathway is used for nuclear, mitochondrial, 
chloroplastic, and peroxisomal proteins. The signal sequences used for different 
organelle targeting is so highly conserved that predicting the location of an newly 
discovered protein can usually be accomplished with just the sequence.56 
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9.2.1 Signal Recognition Protein 
The co-translational pathway is characterized by its own signal recognition 
protein (SRP) and dependence on GTP hydrolysis, similar in structure and function to 
the SRP of bacterial T2S.57 The system contains the SRP, the SRP receptor, a GTPase 
that contacts the SRP, SRP receptor and ribosome, and an ER translocation pore. This 
SRP binds to the nascent peptide (N-terminal) and halts translation until the ribosome/ 
mRNA/ SRP complex is directed to the ER. Hydrolysis of GTP leads to conformational 
changes that reactivates translation and sends the peptide into the ER or the 
membrane.5 The signal itself lacks any precise sequence arrangements, but recognition 
seems to be based on hydrophobicity of the peptide and possibly the secondary 
Figure 9.2 Summary of Eukaryotic Protein Targeting. Image adapted from Lodish et al. 
Copyright W.H. Freeman and Co.55  
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structure (α-helical structures are formed in the output channel of the ribosome). Even 
though the crystal structure of prokaryotic and eukaryotic ribosome-SRP complexes 
have been solved, the exact mechanism of peptide recognition has not been confirmed, 
mainly due to the differences in sequence.   
The lumen of the ER is an environment full of chaperone proteins which facilitate 
proper folding before the protein makes its way to the Golgi network from the cis face 
and is subsequently glycosylated and further directed to the cellular membrane with a 
series of insertion and stop transfer sequences or outside of the cell in a secretory 
vesicle. These insertion and stop transfer sequences are located between the 
transmembrane domains and signal the machinery to move to the next portion of 
transmembrane section of protein or to release the finished synthesis product.  
9.2.2 Tail-Anchored Proteins 
There is a distinct group of eukaryotic substrates that are delivered to the ER 
membrane in a post-translational mechanism, called Tail-Anchored proteins (TA). The 
TA signal is part of the C-terminal domain, so it can only be recognized by cytosolic 
targeting factors when translation has completed, similar to bacterial T1S. Proteins 
encoded with the TA signal are destined for the membranes of various organelles and is 
transported to the respective location by vesicles that bud from the Golgi apparatus.58 
There are two separate ATP-dependent processes that deliver TA proteins to the ER, 
one uses a heat-shock protein chaperone complex while the other uses a cytosolic 
ATPase, ASNA1, that also recognizes a signal sequence. Both pathways maintain 
translocation competence by minimizing misfolds, but the mechanism is relatively 
unknown beyond the initial substrate recognition event. What is known is that the nature 
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of the signal sequence seems to be a determinant of the pathway TA proteins take, as 
more hydrophobic C-terminals favor the ATPase pathway.5 
9.2.3 Post-translational Modification and Regulation 
In many eukaryotes, a simple polypeptide chain is not enough for a protein to be 
fully functional, and there are a variety of post-translational modifications that have been 
described in eukaryotic cells. Methylation, acetylation, phosphorylation, and 
glycosylation are all common modifications that can elicit different recognition or 
regulation responses. There are countless situations where a single mRNA transcript 
can form various translation products based on variation in intron splicing or 
mistranslation from a wobble position in the ribosome, but evidence is now building that 
identical translation product proteins can be targeted to different parts of the cell based 
on post-translational modifications,59 including competition between different 
modification enzymes for the same modification position.60 
If a protein is targeted outside of the cell or to the outer membrane, it traverses 
through the ER to the Golgi network accumulating various modifications and further 
processing, e.g. the cleavage of proinsulin to form insulin, and the type and extent of 
modifications varies between species. This process is one of the reasons that 
prokaryotic systems have trouble producing certain eukaryotic proteins, as they simply 
lack the appropriate modification pathways. There have been cases where prokaryotes 
have been transfected to express eukaryotic glycosylation enzymes to produce viable 
products, but this process can only be done effectively when the modification enzymes 
are known and non-toxic to the host cell. Considering the premise that excessive 
genetic manipulation can create a convoluted, possibly nonfunctioning system, a more 
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reasonable, and promising, method for appropriate post-translational modification in 
recombinant proteins would be to use eukaryotes themselves. 
10 CURRENT SYSTEMS FOR RECOMBINANT PROTEIN SECRETION 
Recombinant protein production has been a staple for all types of biotechnology 
for decades. Industries and universities rely on the availability of specific proteins, but in 
all the capacity of current molecular biology, the problems of yield and purification are 
still present. The ability of many organisms to secrete proteins naturally has led to the 
interest in producing proteins and exporting them outside of the cell, away from large 
amounts of contaminants and degrading elements and minimizing the physiological 
impact. The appeal of maintaining a constant state of recombinant protein export 
without lysing the protein generators is of particular interest to an assortment of 
industries, such as those manufacturing enzymes for detergents, paper processing, or 
food production. Medical researchers are interested in the use of cells that can secrete 
immunogenic proteins and act as live vaccines. Currently, secreted proteins consist of a 
fraction of the total recombinant protein produced in various areas, but the potential for 
increased utility is great. This potential can only be realized however with considerable 
thought and effort into the basic knowledge of secretion systems. 
Bacteria are the most efficient producers, but they are unable to perform certain 
post-translational modifications to eukaryotic cells. This discrepancy in capabilities 
between secretion systems leads researchers to consider different options when 
designing a production system. As the target peptide is the factor on which all design 
plans focus, it's promising to know that protein-based host selection and promoter/ 
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signal peptide optimization are known to yield 3-10 fold increases in specific secretion 
over wild type strains.54 In a shift of focus from general cell biology towards a more 
applicable direction, this chapter outlines a series of model organisms that have been 
utilized for protein secretion, either for their familiarity, robustness, or secretion capacity. 
10.1 Escherichia coli 
E. coli is a well studied bug, and several reviews have given perspective to its 
positive and negative qualities as a secretion platform.9-10,12,61-62 This has made it one of 
the most popular systems for protein production due to the knowledge of its ability to 
process a complex number of secretion signals through its variety of export systems.63 
This enthusiasm for E. coli was frustrating to an extent, because the species itself does 
not have an incredible capacity for secretion in general, but directed mutation and the 
generation of new strains has allowed for novel strategies to be used for an increase in 
yield by eliminating some of the issues, as is discussed further in Chapter 5. The extent 
to which E. coli has been studied means that its secretion pathways are well 
characterized, which adds a degree of simplicity to researchers designing a protein 
production system. Narayanan et al.14 have compared T1 and T3SSs of E. coli in their 
capacity to export a heterologous lipase from Pseudozyma antarctica, named PalB, by 
fusing the enzyme to HlyA and a flagellar protein gene fliC, and found that the HlyA 
pathway secreted PalB faster and to a higher extent. It is worth noting that the flagellar 
T3SS still produced extracellular PalB and there are cases where the flagellar signal 
sequence gave proteins in higher yield, but is suggested that the similarity to the 
flagellar protein's sequence is a determining factor.64 Narayanan also reports that the 
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extracellular secretion of PalB made disulfide bond formation more effective and the 
protein less susceptible to proteolysis. 
Other secretion signals have been compared in E. coli, most as simple fusion 
products, but others as large constructs. Chung et al. have demonstrated that attaching 
the T1SS signal lipase ABC transporter recognition domain (LARD) to recombinant 
proteins can encourage significant amounts of recombinant protein to concentrate 
extracellularly.65 The ECUT tag characterized by Paal et al.66 was designed as a 
strategy to prevent inclusion body formation and purity of final product. The tag contains 
a secretion signal from the periplasmic protease inhibitor ecotin fused to a ubiquitin 
sequence and then the peptide of interest from N to C-terminus. The ubiquitin segment 
of the fusion product is to allow the fidelity of the target peptide‟s N-terminus, as 
deubiquitinating enzymes can be added and cleave the ubiquitin-secretion signal 
peptide highly selectively away from the peptide of interest.  
E. coli also has an advantage over other producers due to its extent of study: a 
large number of expression systems are known. Some problems with protein production 
arise when an expression system is not tightly regulated and can lead to unwanted 
expression at inopportune times, such as different growth phases or has translation 
rates that are too high or too low. An ideal expression system will only induce the 
protein of interest when the timing actually calls for it, i.e. only controlling one gene. The 
expression of a certain protein when it is not appropriate can lead to the formation of 
inclusion bodies or culture death, and so an expression system without negative side 
effects is reasonably desired. A few notable expression systems characterized recently 
contain the ideal qualities of an expression system and have begun to work their way 
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into a larger scale. The pNEW system characterized by Choi et al.67 is very tightly 
regulated and is controlled by a cumate gene switch. The authors claim that, in 
constrast to the pET system, cells containing this switch remain fully induced for longer 
time periods, leading to a 2 to 3 fold increase in target protein yields.  
10.2 Streptomyces lividans 
Streptomyces is a second prokaryotic model genus employed in many instances 
because of its high innate secretion capacity, however their yields for eukaryotic 
proteins has remained rather low. S. lividans is the preferential species host for 
recombinant protein production because they lack certain impeding processes present 
in other Streptomyces species.19 There are several proteins critical in biotechnology that 
are produced at a higher level in S. lividans than E. coli, namely thermostable 
phosphotases and cellulases.68 This is believed to occur because the native signal 
sequence of the Thermus enzymes was able to be processed by Streptomyces, and 
alludes to S. lividans being a viable source for many industrially relevant enzymes. A 
majority of the proteins secreted in S. lividans utilize a TAT pathway, which correlates to 
less bottlenecks at the translocation stage because of the increased concentration of 
machinery, especially if some naturally secreted proteins are knocked out.69 
Unfortunately, for several proteins the results for S. lividans were low, and the 
bottlenecks and checkpoints involved remain unidentified. Some ideas regarding the 
bottlenecks come from the fact that Streptomyces has a fairly biased codon usage 
pattern, due to its high genomic G-C content (roughly 70%),70 which can clog translation 
machinery in the search for rare tRNA molecules. In fact, regulation of some 
Streptomyces genes are thought to be influenced by these rare codons, intentionally 
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slowing the translation of certain genes involved in colony morphogenesis or the 
metabolism of secondary compounds.71 Therefore, care must be used if attempting to 
exchange certain codons or to overexpress the respective tRNAs. 
 Another challenge in Streptomyces protein production is the knowledge of 
appropriate promoter systems. Many constitutive promoters have been identified, but 
suitable inducible promoters are still rare. Rodriguez-Garcia et al. have reported the 
construction of a highly inducible and tightly regulated promoter system for 
Streptomyces using tetracyclin72 and an ε-caprolactam induced promoter system for a 
nitrilase gene of Rhodococcus rhodochrous has shown promise for use in 
Streptomyces,73 but further study into these processes is necessary before 
Streptomyces can be used as a more universal protein production system.  
10.3 Saccharomyces cerevisiae 
When assessing systems for secretion potential, one must inescapably consider 
fungi. The entire existence of fungi can be explained by their ability to decompose 
organic matter, and they do this by secreting fairly large amounts of protein. However, 
the more complicated the organism, the more complicated its secretion pathways, 
leading most research to be based on yeast and small filamentous fungi.74 The 
regulatory systems guiding transcription and translation within eukaryotes tend to limit 
yields as well as prevent certain heterologous proteins from being expressed.75  
However, these are systems that are incredibly valuable for their ability to post-
translationally modify proteins (glycosylation, proper disulfide bond formation, proteolytic 
editing) and the increasing amount of knowledge regarding these systems, most notably 
S. cerevisiae.6 The addition of S. cerevisiae N-terminal secretory signals to recombinant 
80 
proteins has been well established,76 and when the full pre- and pro- cleavage sites of 
the signal are intact at translation, they are processed in a stepwise manner during ER 
and Golgi translocation. On the other hand, S. cerevisiae has one of the highest known 
glycosylation capacities, and can sometimes lead to hyperglycosylated proteins that are 
targeted for degradation.77 
In the past few years, many trials of optimization have led to several published 
(but more commonly proprietary) protocols for protein production by fungi. The most 
common hurdles in procedural design involve vector and induction choices, as well as 
regulation of ER stress responses and proteolytic degradation.54 There are studies that 
show the half life of most recombinant gene-containing plasmids used by scientists 
trying to induce protein expression is on the order of hours, and the most effective way 
to have long-term production of the protein of interest is to actually ligate the gene into 
the genome of the organism. Yeast are the most effective long term eukaryotic 
producers of proteins because they are transfected easier than other eukaryotes. 
Choice of inducer is a critical point in design because often there is too much of 
an influx of protein within the ER when transcription and translation of the recombinant 
protein is switched on and so the folding and transporting machinery inside the ER is 
overworked and cannot properly fold all of the influxing peptides. This increase in the 
concentration of misfolded proteins leads to ER stress responses built into the systems. 
One type of stress response is the unfolded protein response (UPR) that induces the 
transcription of genes that code for proteins involved in protein folding, modification, and 
transport. This is not an immediate fix however, and when the ER is under prolonged or 
excessive stress, it will activate the ER-associated protein degradation (ERAD) 
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response, which funnels unfolded or misfolded peptides into vacuoles that become 
lysosomes to digest the excess peptides. This is not an S. cerevisiae specific problem, 
as almost all eukaryotes exhibit some sort of ERAD response, but the high secretion 
capacity of yeasts is coupled with an effective ERAD system. Another reason for lower 
yields in fungal production is the fact that most fungi secrete proteases regularly, and 
these proteases begin to digest recombinant proteins once they both make it out of the 
cell. 
10.4 Pichia pastoris 
While S. cerevisiae was the first eukaryote used in industrial protein production, 
Pichia pastoris is now the most frequently used yeast species for heterologous protein 
production.6 This is because it has a higher secretion capacity as well as a translation 
efficiency that allows a P. pastoris strain with one or two gene copies produce the same 
amount of extracellular protein as S.cerevisiae with 50 copies.78 This fact especially 
alludes to further utilization of these yeast for recombinant protein production. 
Systems biology has already been used in transcriptomic studies of P. pastoris 
cells expressing recombinant human trypsinogen versus non-induced cells and 
discovered many secretion helper genes.79 This in addition to the genome sequencing 
and analysis which has been done recently80 leads P. pastoris to being a big player in 
future process development. Temperature studies have also been conducted, and the 
number of industrial products using P. pastoris sourced enzymes is increasing. One 
downside to its use is its failure to meet food grade requirements, which limits the 
industrial uses only slightly.  
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10.5 Aspergillus niger 
A filamentous fungus, such as the Aspergillus genus, can grow almost 
indefinitely if there is a steady stream of vesicles moving towards the growing cell tip, or 
hypha. Filamentous fungi possess the highest known secretion capacity,81 but if an 
organism is restricted in its growth, then it will subside from its secretion of protein at the 
hyphae. To outwit the limiting factors of fungal production, one must be familiar with the 
big picture. It has been demonstrated that adding amounts of silica or aluminum oxide 
particles and varying culture conditions can lead to increased branching within A. niger 
batches.82 Unfortunately at this time, even though their secretion of homologous 
proteins is unsurpassed by any other system, the production of recombinant proteins 
has not been able to match those numbers.6 The hypothesis proposed to explain this 
phenomenon is the presence of restrictive processing machinery involved in the correct 
folding and transport of fungal proteins. 
Even though Aspergilli have been industrially useful for decades, there is still little 
known about their physiological and genetic characteristics. There has also been a lot of 
work regarding the regulation or expression of genes that can affect protein folding or 
transport, and strains have been cultivated that express high levels of chaperone 
proteins, glycosyltransferases, and export machinery while down regulating the 
transcription of ER-specific proteases. However, there are enough studies83 to show 
that an increased chaperone level or a decreased protease level does not invariably 
lead to an increase in product recovered.  
In addition, Aspergilli have been used in food and beverage processes for over 
1500 years, in the production of koji foods and cheeses, as well as being a key 
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producer of enzymes such as glucoamylase for corn syrup refinement and α-
galactosidase for digestive supplements. The FDA and WHO have given Aspergillus 
niger fermentation a generally regarded as safe designation, and this acceptance in the 
food industry could easily be carried over into the production of medically relevant 
proteins, especially since they give glycosylation patters similar to mammals, with much 
lower undesired hyperglycosylation levels compared to other fungal systems.84 
The downside to Aspergilli as a recombinant production platform is the difficulty 
of transfection. No natural plasmids have proven effective, but stable integration into 
chromosomal DNA has worked in a way. Transformed DNA fragments are randomly 
inserted into the chromosome, and plasmid integrations usually results in tandem repeat 
integrations.85 The outcome is not easily reproduced or compared. Another complication 
arises, because gene regulation in fungi occurs at the transcription level, where the 
gene copy number is essentially independent of expression rate, due to limiting 
concentrations of transcription factors. However, when one can viably insert inducible 
promoter sequences (usually carbohydrate based and combined with minimal media 
growth conditions) into Aspergilli, they work effectively for intracellular expression, and 
are capable of separating growth and production stages.81 This is not an ideal situation 
for a secretion system, but the genes of certain transcription factors or translation 
elements could be included to upregulate appropriate machinery for increased secretion 
potential. Many promoter systems have been proposed and are being explored, and 
some of the goals for an ideal promoter would be easily controllable and highly 
sensitive, such as a metal ion responsive regulator system.86 
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10.6 Insect and Mammalian Platforms 
Cell lines of higher organisms, such as silk worms (Bombyx mori), have shown to 
be successful secretion platforms. Silk worm cells have been successfully infected with 
a benign baculovirus expression system encoding human interleukins and a silk worm 
secretion signal sequence. These silk worm cells are of interest because they can form 
disulfide bonds and when the expression vector is successfully designed, the secretion 
level can match the expression level. The yields are considerably lower in this system, 
but it has the ability to synthesize human proteins with minimal discrepancies in post-
translational modifications. The signal seems to be dependent on positively charged 
residues at the N-terminus, and is called signal peptide 1 (SP1) because it is found 
abundantly secreted into the silkworm haemolymph.87 
Chinese Hamster Ovary (CHO) cells have also been used recently in the 
production of high value therapeutic proteins such as monoclonal antibodies and other 
immune factors. The capability of CHOs to produce human proteins with high homology 
is undercut by the low secretion levels current constructs have demonstrated. 
Recombinant protein production levels have increased 100-fold over the past twenty 
years due to genetic manipulation of chaperone pathways and process control, to the 
extent that some systems yield g/L scale.88-89 The point of using these systems is that 
they can produce pharmaceutical grade protein products, and the only way to achieve 
this is to direct the products to the secretion pathway. Regrettably, the secretion 
production levels are currently lower than the intracellular production levels, which do 
not always lead to fully mature proteins. Work is being done however, and several 
chaperone proteins have been identified and overexpressed to the effect of increased 
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secretion and immunogenicity of human immunoglobin G proteins compared to control 
induced cells.90 
11 CHALLENGES OF RECOMBINANT PROTEIN PRODUCTION 
Protein production has made significant progress over the past decades, but 
there are still problems that plague both intra- and extracellular production processes. 
According to Ni et al., there are four main strategies employed for engineering 
extracellular proteins: Optimizing well characterized secretion systems and fusing the 
signal to the protein of interest, fusing the protein of interest to a carrier protein without a 
known translocation mechanism, mutation of certain cell envelope proteins to create 
leaky cells, or coexpression of a lysis promoting protein.10 This simplified outlook, while 
relevant for preliminary troubleshooting, does not fully address some of the more 
complicated issues that occur between translation and export nor avoids unnecessary 
cell lysis. This chapter assesses some of the more common issues encountered, with a 
focus on solutions for extracellular secretion systems. 
11.1 Protein Misfolding 
A majority of the secretion systems mentioned in Chapters 2 and 3 require an 
unfolded protein to transverse the secretion channels. T1SSs, by the nature of their C-
terminal secretion signal, must export the protein after translation, and in the case of 
many recombinant proteins without properly expressed chaperone proteins the peptide 
begins folding upon release from the ribosome, potentially clogging the T1SS 
transmembrane pore and resulting in secretion machinery bottlenecks.8 T3SS 
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dependent proteins, such as flagellar precursors, are also secreted in an unfolded form 
and fold upon polymerization.14 
One strategy used in bacterial and yeast systems to improve protein folding is to 
overexpress different chaperone proteins. This takes an effort to determine which 
chaperones will be effective, however. BiP, a commonly expressed chaperone in S. 
cerevisiae has been shown to increase the secretion of some proteins while decreasing 
the secretion of others.54 
An inherent problem with eukaryotic protein secretion is the complicated 
mechanism eukaryotic proteins go through before exiting the cell, and each of the steps 
is regulated and proofread. The UPR and ERAD are more involved as organisms get 
more complex, and if the flux of protein into the ER is too high, then both are activated. 
An ideal situation would be to activate the UPR to assist in the proper folding and 
transport of the newly synthesized peptides without initiating the ERAD, risking the loss 
of product as the misfolded peptides are degraded. It is promising, however, to note that 
there have been studies that show that overexpression of UPR chaperones can lead to 
an increase in protein secretion.91-92 
11.2 Disulfide Bond Formation 
Closely related to the misfolding problem is the incorrect formation of disulfide 
bonds. If a protein has an erroneous disulfide bond network, it cannot possible fold 
correctly, but this is separate in consideration because of the fact that a protein can be 
folded appropriately yet not form the disulfide bonds due to the reducing character of its 
environment. In prokaryotic systems, the cytoplasm is a reducing environment, and so 
most proteins that require disulfide bond formation are directed to the periplasm, where 
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the cysteines can be oxidized.93 These properties often lead to the misfolding of 
recombinant proteins that remain in the cytoplasm of the production system. E. coli 
characterized by a mutation in the thioredoxinreductase gene trxB were shown to have 
an inhibitory effect on protein secretion via the hemolysin pathway due to the cytoplasm 
losing its reductive potential and causing premature disulfide bond formation.94 However 
there have been reports of a strain of E. coli, named Origami B (DE3) which contains an 
misexpression of certain cytoplasmic redox enzymes that leads to an oxidizing 
cytoplasm and fully capable of forming disulfide bonds within the cytoplasm.95 Strategies 
for the appropriate formation of disulfide bonds in E. coli recombinant proteins have 
been reviewed extensively by de Marco.20 Eukaryotic systems have many inherent PDIs 
in the ER that assure proper disulfide bonds form, and there is evidence that changing 
the expression levels of certain ones can lead to increase secretion of heterologous 
proteins.96 
11.3 Codon Usage and Discrepancies 
It has been claimed that codon usage is the single most pressing issue in 
prokaryotic expression, especially in the attempt to express eukaryotic genes.70 The E. 
coli strain B834pRareLysS has been demonstrated to provide a higher number of rare 
tRNAs to the pool within a particular cell to aid in the expression of eukaryotic genes in 
a prokaryotic system.97 The Codon Usage Database98 is an incredible tool to compare 
the differences in codon frequencies between over 35,000 species, and should be 
consulted when trying to overcome codon usage issues. 
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11.4 Other Machinery Bottlenecks 
The definition of overexpression states that there is an abundance of a particular 
protein within a cell, and it follows that if you overexpress a protein that is directed out of 
the cell without increasing the number of translocation complexes, the system can 
become saturated. This is easily related to a busy grocery store with only a single open 
check-out lane. When designing a system for protein expression, one decides on an 
appropriate signal processing pathway. The post-translational pathway seems to be the 
most common in yeast protein secretion, but these proteins require a certain amount of 
chaperone proteins to maintain secretion competence, or a largely unfolded state to 
allow passage through export channels.54 Heterologous protein production between 
prokaryotes and eukaryotes has been difficult because of the difference in or lack of the 
chaperones. In addition, there are several other limiting factors that can diminish 
extracellular protein content, such as regulation of transcription and translation, 
deficiencies in transport machinery, inherent degradation and other quality control 
mechanisms. There have been several strategies used to minimize certain hang-ups in 
the protein production process. 
In the case of the TAT pathway, the signal sequence must be cleaved before the 
exported protein can be released from the translocation apparatus. Four different 
proteases have been identified in Streptomyces that recognize the signal sequence, 
and they are hypothesized to compete for the binding of the precursor proteins and 
cleave with different efficiencies in a regulatory manner.19 This could be a lead to pursue 
when using TAT dependent secretion, as the deletion of a certain signal peptidase that 
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binds tightly while cleaving inefficiently and the overexpression of a faster cleaving 
peptidase could greatly affect the translocation rate. 
It was mentioned in Section 8.2.2 that the TAT pathway has a low level of protein 
secretion in normal conditions, but the overexpression of TAT translocation elements 
can increase the export of GFP,22 while the deletion or inactivation of the same 
translocation elements can actually increase secretion via the Sec pathway for some 
recombinant proteins.69 The TAT pathway carries peptides across the inner membrane 
by using the proton-motive force, and it has been shown that the increase of PMF 
maintenance proteins can increase the secretion of TAT dependent peptides in 
Streptomyces.99 
Another way to get around the low natural secretion level of the TAT pathway 
has been to combine a signal fusion sequence with some crafty genetic engineering to 
produce reasonable amounts of extracellular protein. A deletion of a certain lipoprotein 
in E. coli has given an increase in extracellular protein production, by means of a „leaky 
membrane‟ that allows the recombinant protein to pass through the outer membrane 
upon direction to the periplasm.100 There are some concerns to this technique however, 
as the permeabilization of the outer membrane can seriously deteriorate the 
physiological state of the cells producing the protein.14 It is interesting to note, however, 
that this mutation can cause different effects on cell growth depending on what protein 
is being expressed, some can seriously diminish growth while others have no significant 
effect.100 Various other proteins that can solubilize or permeabilize the outer membrane 
when overexpressed include Kil and Tol-A in E. coli.20 Others claim that it is easier to 
simply add a nonionic detergent to the culture medium to lyse the outer membrane upon 
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direction of protein to the periplasm, but this can cause a decrease in overall production 
because of the physiological effects of outer membrane lysis diminishes growth.101 
Many microbes use extracellular proteases for digestion of sustenance, 
construction of biofilms, or protection from foreign threats. However these proteases 
can wreck havoc on yields, and so significant effort has been involved in minimizing this 
factor. The initial strategy was to supplement growth media with protease inhibitors, but 
this technique can inhibit necessary proteases that are within the cell, leading to an 
aggregation of dysfunctional proteins within the cell. More recently, genetic manipulation 
has lead to the develop multi-protease deficient strains of yeast that have up to a 30-
fold increase in human growth hormone (hGH) secretion, impressive considering the 
high proteolytic sensitivity of hGH, while the addition of PDIs and the deletion vacuolar 
sorting receptor genes in combination with protease deficiency leads to another 50-
100% increase in hGH production.102 Certain Aspergillus strains with multiple protease 
deletions have also resulted in significant increases in recombinant protein secretion.81 
11.5 Scale-Up 
To add to the list of problems one can encounter when designing a protein 
secretion system, many protocols that produce large amounts of proteins in a shake-
flask or other microreactor begin to lose their efficiency when the scale of production 
increases. Nutrient delivery begins to fall subject to diffusion and uptake rates when the 
culture volume and populations are larger. Homogenous conditions are difficult to obtain 
within a reactor, and the physiological attributes of different species can have different 
effects on bioreactor growth. Many types of bacteria form biofilms at certain cell 
densities, and these structures can cause havoc on transport processes. Some 
91 
secretion systems, such as Streptomyces or filamentous fungi species, naturally live a 
mycelial lifestyle, forming pellets at certain levels of cell density which do not allow 
proper oxygen and nutrient flow to the center of the mycelium. An approach to this 
problem is to knock-out expression of genes responsible for peptidoglycan maintenance 
to discourage correct mycelia formation. This approach has been shown to increase 
growth rate of Streptomyces by 40% and secretion of target proteins 2.5 times wild-type 
levels.103 In filamentous fungi, as stated in Section 10.5, have shown to be susceptible 
to morphology alteration. The addition of talc microparticles increases the formation of 
hyphal tips, the site of secretion in these species, and thus the secretion capacity. This 
technique has shown to be effective in both small, shake-flask settings and even more 
so in larger fed-batch reactors, as Driouch et al. have reported a tenfold improvement in 
the extracellular production of a fructofuranosidase from Aspergillus niger.104  
Any bioreactor design is going to have to address gas transfer, nutrient mixing, 
and shear stress.105 Stirred-tank reactors use an internal propeller system to mix 
nutrients. Wave bioreactors rock back and forth to mix the contents. Countless other 
designs are possible, but most use a system for nutrient delivery called a fed-batch. 
Fed-batch reactors are devices that are well established in biotechnology settings, and 
are characterized by the carefully monitored administration of nutrients to the culture in 
an effort to control growth rates and reaction conditions.106-107 Tightly regulated, 
inducible promoter sequences are used in typical fed batch reactors, and when cell 
density has reached the appropriate level, the genes are induced. Fed-batch reactors 
are ideal systems for inducible promoter sequences because of this inherent ability to 
control nutrient levels.  
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Systems biology could be effective in determining factors related to cell growth 
and division that would need to be controlled in a reactor setting. There is a premise 
involved with intracellular recombinant protein expression that encourages cell culture 
growth to a level where cell density is at a maximum before lysis and purification steps 
take place. However, this premise is counter intuitive to the secretion strategy. The 
culture, upon induction, exhausts itself synthesizing as much product as possible. When 
the system is fatigued, the cultures are removed and lysed, the protein of interest is 
purified, and the system is restarted with fresh media and seed cultures. This would 
make the secretion argument invalid, because it hinges on the idea that protein 
extraction is a one-time process. From an export viewpoint, the optimal cell density 
would be lower than the maximum cell density because there is a need for proper 
metabolite concentrations if a cell is to remain viable. For continuous protein production 
and export, the culture medium must not be exhausted of metabolites, and so growth 
inhibitors will probably need to be used to maintain an appropriate cell density during 
production stage. This 'appropriate' cell density is most-likely target protein and 
expression system dependent and further optimization is needed in many instances. In 
a fed-batch reactor however, the concentration of inhibitors could be easily controlled 
within the nutrient cycle of the reactor, and used to maintain cell density within a 
secretion reactor within the effective range without dilution of resources. 
One way to deal with particularly fragile or reactive enzymes in a reactor setting 
is to use a type of scaffolding upon which the enzymes can be linked and immobilized. 
These enzyme-immobilized membrane bioreactors (EMBRs) are generating interest 
because they operate by catalyzing a reaction and separating the end product via 
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solvent flux through the permeable membrane.108 This strategy can maintain reactivity 
in some cases, usually reserved for non-aqueous settings without living cultures, but 
one can imagine the construction of a multi-chambered EMBR that has been designed 
to build metabolites or pharmaceutical compounds in a step-wise process through 
various enzyme-linked membranes. This type of system is not proposed for a secretion-
based production reactor but a post-purification application for the proteins that are 
produced in a secretion system.    
12 PRACTICAL APPLICATIONS 
There are plenty of reasons to pursue protein export as a means to large scale 
production. In any economic climate, purchasing power increases on a macro level 
when the prices of certain commodities drop. In the current political climate, the 
converse of this premise is being applied to arguments regarding the correlation 
between rising health and energy costs and the abjection of our national economy and 
security. Recombinant proteins are being used more and more as alternative 
therapeutics, materials, and energy production mechanisms, but at this time these 
technologies can not compete economically at scale without subsidies or vouchers.   
One way to improve production costs is to increase the efficiency of the 
production process, and, as stated above, using extracellular secretion of recombinant 
proteins is a promising method for that end. Of course, much more research needs to 
be done in almost all of the areas which could employ secretion pathways at the 
production level, but this chapter is a display of instances where secretion of certain 
proteins has demonstrated a proof of concept of economic and/or societal benefit.   
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12.1 Pharmaceutical Production 
The human immune system, to briefly overview, can be described by two 
mechanisms: The innate response and the adaptive response. The innate response is 
non-specific and protects the body against pathogens. It is responsible for initiating the 
adaptive response by recruiting immune cells to the point of infection so that an 
adaptive, specific response can begin. The adaptive response occurs when antigens 
(small, pathogen specific peptides) are presented to T-cells by antigen presenting cells 
(APCs) or dendritic cells (DCs; APCs that also express immune system stimulating 
factors) which triggers a signal cascade ending in the clonal expansion of the antigen 
specific, activated T-cell. This army of T-cell clones attacks the foreign entity and then, 
upon victory, downsize the population to a select few memory T-cells that patrol the 
body searching for a reappearance of the specific antigen it recognizes.109 Modern 
therapeutics are looking for ways to use these processes in conjunction with 
pharmaceutical compounds to minimize side effects and increase the effectiveness of 
certain treatments.   
One strategy has been to create soluble T-cell receptors, as opposed to 
membrane bound and disulfide-linked structures, connected by a flexible segment to a 
specific antigen peptide that can bind to the receptor‟s active site, because the natural 
form has not been successfully expressed and can reversibly bind to the antigen.97 This 
approach works well for x-ray crystallography studies, but in vivo the T-cells must also 
bind to the major histocompatibility complex (MHC) of APCs and DCs for activation to 
occur. Soluble MHCs, however, are becoming more popular targets for recombinant 
production,110 and the hypothesis states that soluble MHC: antigen complexes could 
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travel through the blood and lymph systems priming T-cells for activation against the 
antigen. If structural studies can confirm homology and immunosorbent competence, 
secretion pathways could definitely be employed for pharmaceutical grade production of 
these proteins for therapeutic trials. Antibodies are essentially soluble B-cell receptors 
that follow a similar activation pathway as T-cells, and they balance out the immune 
system‟s responsiveness and specificity. Fernandez et al. demonstrated how both 
short-chain variable fragments (scFvs) and heavy-chain variable fragments (VHH) can 
be secreted as fusion constructs with hemolysin C-terminal sequences in their fully 
oxidized, functional form.94,111Another method proven to produce functional, fully 
glycosylated antibodies uses an engineered signal sequence based on the α-mating 
factor (αMF1) of S. cerevisiae, when combined with strain optimization, led to significant 
a 180-fold increase in extracellular production of human IgG1.112 The αMF1 is a fairly 
conserved secretion signal in eukaryotes and consists of two cleavage points; one for 
the ER, one for the Golgi. It has been used a fair amount for the secretion of 
recombinant proteins, but its success as a secretion signal greatly depends on its fusion 
partner.113 
One issue is that scFvs contain at least one disulfide bond in each chain, and this 
must be considered when producing these molecules. A creative way around this 
problem and to allow scFvs to be produced more effectively in prokaryotic systems is to 
mutate the protein to fold without the disulfide bonds, which has been implemented in 
recombinant protein production but not yet demonstrated via a secretion pathway.114-115 
Hormones are another type of biomolecules that can be used as therapies. They 
are small peptides that initiate various responses within the body. One of the more 
96 
highly produced hormones is insulin, which is reasonable because as diabetes cases 
continue to rise, the demand for insulin and proinsulin have increased dramatically. In 
vivo production of insulin proceeds through several steps of folding and cleavage from 
an initial translation product into the heterologous dimeric active form. In current 
industrial processes, proinsulin has been fused to the E. coli protein ecotin and shown 
to form correctly in the periplasm of E. coli, but the naturally occurring proteases within 
the periplasm still keep yields low in E. coli.116 In S. cerevisiae proinsulin production is 
hampered by hyperglycosylation and inability of the yeast to successfully process the 
human proinsulin.117 However, it has been reported that proinsulin-like peptides without 
certain glycoslyation sites can be processed by the secretion pathway and an in vitro 
cleavage step will yield a semi-functional insulin molecule.118 The use of microbes to 
produce insulin is gaining support from the markets as well, considering that most 
pharmaceutical insulin is isolated from pigs, and religious beliefs cause some diabetes 
sufferers to deny porcine-sourced medicines. Additionally, the demand for insulin is 
exceeding what the farming industry can provide. 
Other chemokines responsible for directing cell transport within the body, such as 
inflammatory responses or angiogenesis, have been the target for drug discovery in 
recent years, and development has been made into their production within prokaryotic 
systems. The main challenge with their production is maintaining an intact N-terminal 
sequence after purification, and a few strategies have worked well in intracellular 
expression.95 The inclusion of a ubiquitin tag within the fusion product, as described by 
Paal et al.,66 could be used in secretion and then accurate cleavage of the cytokines 
away from the fusion construct. 
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12.2 Live-Vaccine Therapeutics 
The bulk production of pharmaceuticals via recombinant protein export is an 
extremely promising concept which is in various stages of scaling up, depending on 
what product is being discussed. However, there are more delicate medical problems 
that could benefit from protein export and a different approach. The T3 and T4SSs is a 
very complicated process with tight regulation of timing and structure development,119 
which would be inefficient as a bulk protein production pathway, but cancer, hemophilia, 
sickle-cell anemia, and afflictions based on other genetic misregulations could be 
targeted by pathogen-like bacteria expressing antigens or inhibitory peptides that can 
be directed into infected cells.  
The use of bacteria in cancer therapy has taken two different routes. First, 
bacteria are systematically or directly administered to the tumor itself, and bacterial 
replication within tumor cells leads to tumor regression. The second uses bacteria as 
antigen delivery particles to develop cancer specific immune responses. Some strains 
of Salmonella offer a potential means to deliver antigens to CD8+ T-cells to stimulate 
cytotoxic activity against tumor cells. This system has even been claimed to sensitize 
tumor cells to preexisting, circulating CD8+ cells.120 This technique has been used in 
both cancers with and without a known infectious origin, and if a proper peptide is 
administered with a high enough efficiency it can theoretically induce an immune 
response and would be an important therapeutic strategy because it would not require 
full genetic knowledge of the tumor‟s antigenic content.120 Avirulent bacteria vectors, 
pathogens with certain virulence genes deleted, offer a reasonable approach for this 
type of therapy. Their genetics are understood and relatively easy to manipulate, to the 
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extent that the strains can be engineered to express several antigens. They can also be 
grown and administered cheaply, and can act as their own adjuvant to initiate an 
immune response.121 Specifically, avirulent Salmonella has recently been used to target 
cancer cells and other autoimmune disorders through its T3SS and the expression of 
antigens or therapeutics. The extent of study so far has been reviewed by Moreno et 
al.122  
Recently, a drive towards the use of T5SSs to display certain recombinant 
proteins in the outer membrane of some gram-negative bacteria has shown to work 
rather effectively, much more effectively than the use of T5SS for recombinant protein 
production.124 This could be another potential route to design a live-vaccine that 
displays certain human cell-surface proteins in an attempt to prolong the in vivo half-life 
of these cultures by immune system evasion. Obviously careful design strategies must 
be employed to discourage the proliferation of virulent, immune-evading pathogens, but 
the allure of more effective therapies warrants further investigation.  In addition, since 
the T4SS has the capability to transport peptides, protein-protein complexes, and 
nucleic acid-protein complexes,123 one can imagine the creation of highly specialized 
live-vaccine cells using two different secretion pathways for different products to 
minimize competition for the transport machinery. 
12.3 Energy Production 
Cellulose is the most abundant biopolymer on the planet, and thus being so, it 
currently has several applications as a renewable resource in many industries, including 
paper and clothing production, the stationary phase in most thin-layer chromatography 
plates, and “green” building insulation.125 Its sheer abundance and the relative ease of 
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replacement gives cellulose enormous potential as an energy source. The chemical 
composition of cellulose is relatively simple, as the polymer consists of several 
thousand glucose residues bound together in β-1,4-glycosidic linkages forming long 
strands that are capable of forming hydrogen bonds with neighboring strands that 
increase its stability as well as prohibiting its solubility in water. Glucose is a very 
energy-rich compound, and this energy can be used by industries via production of 
biofuels or other organic compounds. The most talked about product is ethanol, formed 
during glucose fermentation and a widely used gasoline additive. Other alcohols, such 
as butanol, with a higher energy density have the potential to be a replacement 
altogether. The ability to produce ethanol from cellulosic waste in a cheap and efficient 
manner would be of great importance. There are three types of cellulolytic enzymes that 
are commonly found in nature, and all three are necessary to efficiently break cellulose 
down into its glucose monomers. Every enzyme that hydrolyses cellulose does so by 
cleaving the β-1,4-glycosidic bond between glucose subunits, but the substrate 
specificity is the distinguishing factor. The enzyme β-glucanase, member of the 
endoglucanase family, cleaves internal glycosidic bonds and breaks interstrand 
hydrogen bonds, thereby enhancing the solubility of cellulose and cleaving strands of 
random length from ten to a few hundred glucose subunits. The cellooligohydrolase 
family that cleaves branches sized from two to ten glucose subunits from the reducing 
ends of cellulose. The last type are called β-glucosidases, of the exoglucanase family of 
enzymes, and they cleave glucose monomers from the reducing ends of cellulose 
fibers.126 
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The export of a mixture of these enzymes is normal in the everyday metabolism 
of certain bacteria and fungi, and the engineering of hypersecretion strains with the 
development of efficient cellulase ratios could bring glucose production from cellulose 
feed stocks into a more economically competitive process. Various proteins have been 
identified that enhance recombinant glucanase activity,127 and genetic manipulation of 
these proteins as well as secretory machinery or helper proteins could presumably 
serve as a starting point in a cellulolytic system design. Once the glucose units are 
produced from the cellulose, there are countless products that could be produced with 
all sorts of metabolic pathways.  
Alcohol fuels are easier to produce, and the level of corn and other feedstock 
subsidies make alcohols very tempting to pursue, but they do not have as high an 
energy density as long chain alkanes such as those used in jet or diesel fuel. Recently, 
bacteria have been exhibited to produce a wide variety of fatty acids in response to 
various environmental stressors; the ratio of saturated to unsaturated can vary based on 
growth temperature or the presence of ethanol or other fatty acids in the growth 
medium.128 These fatty acids can be converted to petroleum-like chemicals like long 
chain alkanes for fuel or other industrial purposes. There are a few strategies being 
employed that use different metabolic pathways, which have been usefully reviewed by 
Yan et al.129 Most recently, however, the typical strategy for producing these long chain 
alkanes has consisted of engineering the fatty-acid biosynthesis pathway to 
overexpress the subunits of acetyl-CoA carboxylase to increase the rate of malonyl-CoA 
synthesis, which is widely accepted as the rate-limiting step of fatty acid biosynthesis, in 
combination with the deletion of several β-oxidation enzymes that are responsible for 
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degrading fatty acids if their concentration gets too high. Upon the completed synthesis 
of a C12 or C14 fatty acid, esterification and decarboxylation are the two most common 
ways to obtain a viable fuel product. However, both of these products require the lysis of 
the cultured cells and the extraction of the fatty acids before catalytically creating the 
end product.130  The other approach is to use the cultured cells to complete the 
conversion as the last step in the process. Certain alkane production pathways have 
been discovered in cyanobacteria that have the capability to synthesize C13 to C17 
alkane mixtures and secrete them out of the cell. The main enzyme is an aldehyde 
decarbonylase which removes a carbon monoxide molecule from the end of a long 
chain fatty aldehyde previously reduced from a fatty acid. This pathway has been 
heterologously expressed in E. coli to the extent that alkane levels were comparable to 
the wild-type cyanobacteria.131 The difference in production organism centers on the 
source of nutrition. E. coli needs some sort of carbon feedstock to produce the alkanes 
via respiration while the cyanobacteria, such as Anabaena or Synechoccus species, 
use CO2 and light in photosynthesis. Both processes have scalability issues: E. coli 
requires a certain oxygen level and continuous nutrient flow while high cyanobacteria 
cell density greatly diminishes the transmittance of light into the reactor and can affect 
CO2 uptake rates as well.
132   
There is significant debate as to which method will prove to be the most efficient 
and scalable. Some say that the production of alkanes by the microbes themselves will 
lead to lower yields because of increased metabolic demands, while others argue that 
the loss of product during the conversion processes are comparable to the lower 
secretion yields. In reality, none of these methods is close to replacing petroleum based 
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long chain alkanes as a fuel source. The processes are just being described in 
academically useful ways, and to date no one has published a report of extracellular 
alkane synthesis using membrane bound or extracellular proteins. It is exciting to think 
of this frontier being explored in the coming years now that heterologous recombinant 
alkane biosynthetic enzymes have been achieved.  
12.4 Spider Silk Monomers 
Spider silk is one of nature's most spectacular materials. Stronger than steel by 
weight, they have a large amount of potential uses including medical implants, high-
strength fibers, and drug delivery systems.133 However, the production of native silk 
proteins in a recombinant manner has been problematical through several factors. First, 
the genes of silk proteins contain large amounts of repeat regions, which lead to 
homologous recombination. Second, silk gene codon usage is specialized within the silk 
producing cells of spiders, which can lead to translation stalling and incomplete protein 
production when recombinant expression is employed. Third, a high concentration of 
these proteins within a cell can cause the monomers to polymerize, forming fibers within 
the cell and destroying its ability to continue producing the protein. Widmaier et al.134 
have developed an optimized procedure for minimizing these factors with a system that 
consists of four genetic parts: a signal sequence, an affinity tag, a cleavage signal, and 
the spider silk protein. The construct is designed for E. coli and it uses a salt-dependent 
inducer with low basal transcription rate and no other activity under normal conditions. It 
is also set up to restrict translation of the recombinant protein until after the T3SS 
translocation apparatus has been constructed to negate the formation of inclusion 
bodies. 
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The idea of using spider silk as a material for everyday use is promising, and in 
an ideal situation the monomers could be secreted in their native form to produce a 
mixture that could be 'spun' in an industrially favorable way. This is a little bit further out 
than the other practical applications mentioned in this chapter, but the research is 
happening.  
13 POTENTIAL AVENUES FOR FUTURE RESEARCH 
The process of designing an expression system is inherently dependent on the 
target. The purity and amounts of the said target needed are also requirements in the 
design process, dependent on the end application of the recombinant protein as 
pharmaceutical grade products must be more highly purified than other industrial 
proteins. The synthesis of recombinant proteins can be an arduous task, as the diversity 
of proteins inevitably leads to protocols that either work with minimal tweaking or 
procedures that need months of optimization. Past research has revealed the daunting 
task that is designing a highly efficient system for the production of a specific protein. 
Still, technology is advancing at a promising rate. Sequencing techniques allow for 
characterizations on a cell to cell basis, and systems biology approaches have been 
used to assess the random mutagenesis of various microbes in an attempt to grow 
strains with desirable properties and then transfect them with recombinant genes 
directed to secretion systems.135-136 There is still, however, a fair number of proteins 
with industrial relevance that have not yet been expressed within a secretion pathway. 
The strategies for effective and efficient protein secretion should center on the idea that 
bacteria should be used to produce bacterial proteins while eukaryotic proteins should 
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be produced in eukaryotic systems. There are cases where a bacterial system has 
successfully secreted eukaryotic proteins, but in general the bottlenecks involved with 
trans-domain protein production drastically diminish the yield and quality of the product. 
When designing a protein secretion system, one should keep this in mind. 
Systems biology has had a large impact on the design and characterization of 
secretion systems to date, but the potential of these techniques to quantify and analyze 
the effectiveness of a system has not been actualized, though coding strategies are 
being investigated.137 It would be very beneficial to identify the larger network of genes 
and proteins that are involved in various product- or species-specific secretion 
mechanisms because strains of microbes could be designed with optimized expression 
levels of various chaperones, PDIs, ribosomal elements and export machines towards 
highly efficient processes. Further study into feedback pathways and regulatory 
elements of secretion platforms is desperately needed to expose the current unknowns 
that hinder output.  
In the process of studying processes on a cell-wide scale, the bioinformatics field 
has obtained incredibly large amounts of data over the past few years, and the task of 
digging through multiple databases is daunting. The Wikipedia “List of Biological 
Databases” has over 150 items, constantly changing as old databases are no longer 
maintained and new ones take their place, in a process that is full of redundancies.138-
139 The compilation of the acquired data also needs to occur in a highly organized and 
accessible manner for ease of interpretation and collaboration.  
While it is currently impractical to think of buildings and bridges made of spider 
silk or airplanes that run on microbial fuel cells, and cost-benefit analysis shows that 
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intracellular expression and the subsequent purification is still more effective for certain 
proteins than extracellular secretion,140 advances occur every day that allow for higher 
production levels. There is a minor consensus that the eventual goal of is to develop a 
strain of microbe that can continuously secrete large amounts of a wide range of 
proteins, due to its expression of an appropriate level of chaperones and PDIs, minimal 
protease activity, an excess of transport machinery, and (if eukaryotic) optimized post-
translational modification pathways. This simple and generic production system has 
been called the „Holy Grail‟ by some molecular biologists, but when one considers the 
actual behavior and incredible diversity of secretion mechanisms, a single system that 
can accommodate such a wide range seems like wishful thinking. On the contrary, the 
diversity of secretion systems described in nature can be used to the extent that almost 
any scientist can find a system that will work effectively for their target protein. One just 
has to look around. 
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